<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id><journal-id journal-id-type="publisher-id">biomolecules</journal-id><journal-title-group><journal-title>Biomolecules</journal-title></journal-title-group><issn pub-type="epub">2218-273X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6523335</article-id><article-id pub-id-type="doi">10.3390/biom9040138</article-id><article-id pub-id-type="publisher-id">biomolecules-09-00138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Matos</surname><given-names>Sheila P.</given-names></name><xref ref-type="aff" rid="af1-biomolecules-09-00138">1</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Helder F.</given-names></name><xref ref-type="aff" rid="af1-biomolecules-09-00138">1</xref></contrib><contrib contrib-type="author"><name><surname>de Lima</surname><given-names>&#x000c1;dley A. N.</given-names></name><xref ref-type="aff" rid="af2-biomolecules-09-00138">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1365-7602</contrib-id><name><surname>Veiga-Junior</surname><given-names>Valdir F.</given-names></name><xref ref-type="aff" rid="af3-biomolecules-09-00138">3</xref></contrib><contrib contrib-type="author"><name><surname>Koester</surname><given-names>Let&#x000ed;cia S.</given-names></name><xref ref-type="aff" rid="af1-biomolecules-09-00138">1</xref><xref rid="c1-biomolecules-09-00138" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-biomolecules-09-00138"><label>1</label>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Farmac&#x000ea;uticas, Faculdade de Farm&#x000e1;cia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga, 2752, Porto Alegre 90610-000, Brazil; <email>sheilaporto@outlook.com</email> (S.P.d.M.); <email>helder.teixeira@ufrgs.br</email> (H.F.T.)</aff><aff id="af2-biomolecules-09-00138"><label>2</label>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Farmac&#x000ea;uticas, Departamento de Farm&#x000e1;cia, Universidade Federal do Rio Grande do Norte, Av. General Cordeiro de Farias, s/n, Petr&#x000f3;polis, Natal 59012-570, Brazil; <email>adleyantonini@yahoo.com.br</email></aff><aff id="af3-biomolecules-09-00138"><label>3</label>Departamento de Engenharia Qu&#x000ed;mica, Instituto Militar de Engenharia, Pra&#x000e7;a Gen. Tib&#x000fa;rcio, 80, Praia Vermelha, Urca, Rio de Janeiro 22290-270, Brazil; <email>valdir.veiga@gmail.com</email></aff><author-notes><corresp id="c1-biomolecules-09-00138"><label>*</label>Correspondence: <email>leticia.koester@ufrgs.br</email>; Tel.: +55-51-3308-5278</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2019</year></pub-date><volume>9</volume><issue>4</issue><elocation-id>138</elocation-id><history><date date-type="received"><day>08</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>02</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Essential oils are natural products with a complex composition. Terpenes are the most common class of chemical compounds present in essential oils. Terpenes and the essential oils containing them are widely used and investigated by their pharmacological properties and permeation-enhancing ability. However, many terpenes and essential oils are sensitive to environmental conditions, undergoing volatilization and chemical degradation. In order to overcome the chemical instability of some isolated terpenes and essential oils, the encapsulation of these compounds in nanostructured systems (polymeric, lipidic, or molecular complexes) has been employed. In addition, nanoencapsulation can be of interest for pharmaceutical applications due to its capacity to improve the bioavailability and allow the controlled release of drugs. Topical drug administration is a convenient and non-invasive administration route for both local and systemic drug delivery. The present review focuses on describing the current status of research concerning nanostructured delivery systems containing isolated terpenes and/or essential oils designed for topical administration and on discussing the use of terpenes and essential oils either for their biological activities or as permeation enhancers in pharmaceutic formulations.</p></abstract><kwd-group><kwd>essential oils</kwd><kwd>terpenes</kwd><kwd>nanotechnology</kwd><kwd>cyclodextrins</kwd><kwd>topical drug administration</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-biomolecules-09-00138"><title>1. Introduction</title><p>Essential oils (EO) are natural products extracted by hydrodistillation from plant materials, composed by small, volatile, and fairly hydrophobic molecules [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B3-biomolecules-09-00138" ref-type="bibr">3</xref>]. The functions of EO in plant organisms seem to be related to environmental interactions and protection of the plant against predators and pathogens [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B4-biomolecules-09-00138" ref-type="bibr">4</xref>,<xref rid="B5-biomolecules-09-00138" ref-type="bibr">5</xref>]. In the industry, essential oils are materials of great interest with a wide range of possible applications in the nutritional, agricultural, cosmetic, and pharmaceutical fields [<xref rid="B6-biomolecules-09-00138" ref-type="bibr">6</xref>,<xref rid="B7-biomolecules-09-00138" ref-type="bibr">7</xref>], due to their broad spectra of biological activities such as antimicrobial, repellent, analgesic, anti-inflammatory activity, and many others [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>]. Essential oils can be extracted from plant matrices using different techniques classified as classical/conventional (that use water distillation by heat as a means to extract the whole volatile material) and innovative/advanced (which focus on the improvement of selectivity in extraction efficiency by reducing extraction time, use of energy, solvent, and CO<sub>2</sub> emissions) [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>]. </p><p>Terpenes and terpenoids (the oxygenated derivatives of terpenes [<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>]) are the chemical compounds representing the majority of molecules in essential oil composition [<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>]. This class of molecules is characterized by the combination of isoprene units (C<sub>5</sub>H<sub>8</sub>). Terpenes can be classified according to the number of isoprene units in their structure (e.g., hemiterpenes are formed by one isoprene unit, monoterpenes are formed by two isoprene units, sesquiterpenes by three isoprene units, and diterpene formed by four units) [<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>]. Smaller terpenes, up to three isoprene units, are highly volatile, and the volatility decreases with an increased number of isoprene units [<xref rid="B9-biomolecules-09-00138" ref-type="bibr">9</xref>]. Many biological activities of terpenes and terpenoids are described in the literature, being this class of molecules a valuable source of therapeutic agents with pharmaceutical applications, such as anti-inflammatory [<xref rid="B10-biomolecules-09-00138" ref-type="bibr">10</xref>], wound healing [<xref rid="B11-biomolecules-09-00138" ref-type="bibr">11</xref>], antineoplastic applications [<xref rid="B12-biomolecules-09-00138" ref-type="bibr">12</xref>,<xref rid="B13-biomolecules-09-00138" ref-type="bibr">13</xref>,<xref rid="B14-biomolecules-09-00138" ref-type="bibr">14</xref>]. In addition, some compounds of the class are widely investigated and reported as penetration enhancers for percutaneous drug delivery, being used as excipients in the preparation of nanostructured systems [<xref rid="B7-biomolecules-09-00138" ref-type="bibr">7</xref>,<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>,<xref rid="B15-biomolecules-09-00138" ref-type="bibr">15</xref>]. Smaller terpenes are usually thermolabile and susceptible to volatilization and degradation, mainly by oxidation and isomerization [<xref rid="B6-biomolecules-09-00138" ref-type="bibr">6</xref>,<xref rid="B16-biomolecules-09-00138" ref-type="bibr">16</xref>]. </p><p>The topical administration of drugs consists in the localized administration of formulations to an organism, comprising dermal and mucosal administrations (e.g., ocular, vaginal, nasal, and rectal routes). Among those, the most widely employed is the cutaneous route, which may be attributed to the easiness of access compared to other topic routes [<xref rid="B17-biomolecules-09-00138" ref-type="bibr">17</xref>]. When applied to the skin, a drug delivery system can be considered dermal (when the targeting site of the drug is the skin) or transdermal (when the drug needs to pass through skin layers in order to reach its target); for mucosal tissue administration, delivery can be mucosal and transmucosal [<xref rid="B18-biomolecules-09-00138" ref-type="bibr">18</xref>]. Many issues concerning these delivery routes are described in the literature, such as the resistance to diffusion through the skin and mucosae when aiming towards transdermal or transmucosal delivery and the reduced contact of the formulation with mucosal tissues due to mucus and, thus, reduced drug bioavailability [<xref rid="B19-biomolecules-09-00138" ref-type="bibr">19</xref>,<xref rid="B20-biomolecules-09-00138" ref-type="bibr">20</xref>].</p><p>Encapsulation of essential oils in micro or nanometric systems is an interesting strategy to provide better stability to the volatile compounds and protect them against environmental factors that may cause chemical degradation [<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B6-biomolecules-09-00138" ref-type="bibr">6</xref>]. In addition, the encapsulation in nanometric systems may improve the bioavailability and bioefficacy of formulations as a result of cellular absorption and provide controlled release of bioactive compounds [<xref rid="B3-biomolecules-09-00138" ref-type="bibr">3</xref>,<xref rid="B21-biomolecules-09-00138" ref-type="bibr">21</xref>]. Special nanostructured systems have been designed intending topical administration as approaches to overcome the drawbacks inherent to these administration routes, such as mucoadhesive systems that prolong the contact with mucosae and systems that favor the passage of the drug trough skin or mucosal tissue layers [<xref rid="B20-biomolecules-09-00138" ref-type="bibr">20</xref>,<xref rid="B22-biomolecules-09-00138" ref-type="bibr">22</xref>]. Molecular encapsulation through complexation with cyclodextrins is another strategy employed to improve the stability of essential oil components, avoid volatilization (and, consequently, prolonging contact,) and enhance permeation of the bioactive molecules [<xref rid="B23-biomolecules-09-00138" ref-type="bibr">23</xref>]. </p><p>In recent decades, the interest in nanotechnological approaches and use of natural products have raised great attention in the search and development of drug delivery systems. The present review intends to assess the panorama of research using nanostructured delivery systems containing essential oils and/or their isolated terpenes/terpenoids as bioactive compounds and/or excipients for topical administration routes. </p></sec><sec id="sec2-biomolecules-09-00138"><title>2. Literature Survey</title><p>A literature survey was carried out in three different databases: Embase, Scopus, and Pubmed. Initially, all results found until 31 December 2018 were considered, without limiting the search period before this date. The search terms used were a combination of words related to nanostructured systems &#x0201c;AND&#x0201d; terpenes/essential oils &#x0201c;AND&#x0201d; topical administration route. All classes of terpenes were included, not only low-volatile terpenes, as well as all topical administration routes, which comprise cutaneous and mucosal administration. Database search lines can be found in <xref ref-type="app" rid="app1-biomolecules-09-00138">Supplementary Materials, Table S1</xref>. </p><p>The number of results obtained using Scopus were 87, those from Embase were 365, and those from PubMed were 64. Among those results, only research articles in English were considered for data screening. Also, duplicates were disregarded. In addition, reference lists of papers were screened to detect research papers which did not appear in the database research but might fulfill the acceptance criteria (<xref ref-type="fig" rid="biomolecules-09-00138-f001">Figure 1</xref>). Afterwards, the papers were screened and selected if meeting the following acceptance criteria:<list list-type="bullet"><list-item><p>Original research data.</p></list-item><list-item><p>Use of essential oil containing terpenes and/or isolated terpenes in nanostructured systems or cyclodextrins.</p></list-item><list-item><p>Formulations for topical administration.</p></list-item></list></p><p>Finally, 82 papers were selected for further data extraction. Studies were sorted by year of publication in order to visualize the evolution of research in this field over the years (<xref ref-type="fig" rid="biomolecules-09-00138-f002">Figure 2</xref>). The first report dated from 1989 and was by Saettone et al. [<xref rid="B24-biomolecules-09-00138" ref-type="bibr">24</xref>], who studied the complexation of the diterpene forskolin with cyclodextrin for ocular administration. The number of publications has gradually grown over the years, indicating an increasing interest in the topic.</p><p>Data concerning the essential oil or terpene used, encapsulation system, nanosystem preparation technique, administration route of formulation, and use of EO/terpene as bioactive compounds or excipients were extracted from the selected papers and compiled in <xref rid="biomolecules-09-00138-t001" ref-type="table">Table 1</xref> and <xref rid="biomolecules-09-00138-t002" ref-type="table">Table 2</xref> in order to ease the access to the extracted data, which are further discussed in the following sections of this review.</p></sec><sec sec-type="discussion" id="sec3-biomolecules-09-00138"><title>3. Discussion</title><sec id="sec3dot1-biomolecules-09-00138"><title>3.1. Topical Administration Routes</title><p>Topical drug administration can be described as the localized application of a pharmaceutical dosage form and comprises both dermal and mucosal administration [<xref rid="B19-biomolecules-09-00138" ref-type="bibr">19</xref>,<xref rid="B20-biomolecules-09-00138" ref-type="bibr">20</xref>]. In <xref ref-type="fig" rid="biomolecules-09-00138-f003">Figure 3</xref>, the different sites of administration for nanosystems containing isolated terpenes and/or EO are shown. It can be noticed that among the study formulations containing nanoencapsulated EO and/or terpenes, dermal and transdermal administration represent nearly 90% of the administration routes, which can be attributed to the non-invasiveness, convenience, and painless qualities of this type of administration.</p><p>Dermal administration of nanostructured systems containing terpenes and EO is, in general, mainly used as a treatment for conditions localized on the skin surface, such as for wound healing, and to vehiculate anti-inflammatory, antimicrobial, and repellent agents. On the other hand, transdermal delivery is employed in cases where the bioactive compound needs to reach deeper layers of the skin or even the systemic circulation, such as for anesthetic, antihypertensive, and antidiabetic drugs (<xref rid="biomolecules-09-00138-t001" ref-type="table">Table 1</xref> and <xref rid="biomolecules-09-00138-t002" ref-type="table">Table 2</xref>).</p><p>Mucosal administration (ocular, nasal, oral, vaginal) still represents a challenging route due to the presence of mucus, lacrimal fluids, and saliva, which can impair the bioavailability of the bioactive compound [<xref rid="B19-biomolecules-09-00138" ref-type="bibr">19</xref>]. However, it is possible to foresee the development of mucoadhesive formulations as means to overcome these limitations.</p></sec><sec id="sec3dot2-biomolecules-09-00138"><title>3.2. Role of Essential Oil and/or Terpenes in the Formulations</title><p>In order to understand the applications of EO containing terpenes and/or isolated terpenes encapsulated in nanosystems intended for topical administration, the studies were divided between those in which EO/terpenes were used as excipient and those in which they were used as bioactive compounds. Of 82 studies, 56 employed terpenes/EO as bioactive ingredients in formulations, whereas 29 reported terpenes/EO as excipients in formulations (<xref ref-type="fig" rid="biomolecules-09-00138-f004">Figure 4</xref>). Zhang et al. [<xref rid="B38-biomolecules-09-00138" ref-type="bibr">38</xref>] reported both bioactive (anti-inflammatory) and penetration-enhancing activities of the terpene Paeoniflorin encapsulated in glycerosomes. Also, Castangia et al. [<xref rid="B90-biomolecules-09-00138" ref-type="bibr">90</xref>] described the preparation of permeation-enhancing vehicles containing <italic>Santolina insularis</italic> EO as an antimicrobial and permeation enhancer for percutaneous drug delivery. </p><p>Many biological and pharmacological activities of EO and terpenes are well described in the literature, and the interest in their use as bioactive ingredients in pharmaceutical formulations has been rising recently, alongside with the seek for natural products as alternatives for drug development [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B5-biomolecules-09-00138" ref-type="bibr">5</xref>].</p><p>In general, the use of terpenes as excipients aims to increase the permeation of the active compound through skin layers, since terpenes are extensively cited in the literature as permeation enhancers [<xref rid="B7-biomolecules-09-00138" ref-type="bibr">7</xref>,<xref rid="B15-biomolecules-09-00138" ref-type="bibr">15</xref>,<xref rid="B102-biomolecules-09-00138" ref-type="bibr">102</xref>]. The application of terpenes as excipients is further discussed in <xref ref-type="sec" rid="sec3dot2dot2-biomolecules-09-00138">Section 3.2.2</xref>.</p><sec id="sec3dot2dot1-biomolecules-09-00138"><title>3.2.1. Nanostructured Systems Used in the Encapsulation of Terpenes and Essential Oils as Bioactive Ingredients</title><p>The therapeutic potential of terpenes and EO containing terpenes is well known. Biological activities such as bactericidal, fungicidal, antioxidant, virucidal, and antineoplastic activities are well recognized [<xref rid="B3-biomolecules-09-00138" ref-type="bibr">3</xref>,<xref rid="B5-biomolecules-09-00138" ref-type="bibr">5</xref>,<xref rid="B103-biomolecules-09-00138" ref-type="bibr">103</xref>]. There is a number of good reviews in the literature that list the variety of nanostructured systems and preparation techniques employed in the encapsulation of EO in nanostructures systems [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B104-biomolecules-09-00138" ref-type="bibr">104</xref>], but none focused on terpenes. Among the studies listed in <xref rid="biomolecules-09-00138-t001" ref-type="table">Table 1</xref> and <xref rid="biomolecules-09-00138-t002" ref-type="table">Table 2</xref>, the most widely investigated biological activities upon nanoencapsulation of essential oils and isolated terpenes were the anti-inflammatory activity of essential oils and oil resins containing terpenes, such as plai oil [<xref rid="B93-biomolecules-09-00138" ref-type="bibr">93</xref>], <italic>Copaifera multijuga</italic> oil [<xref rid="B89-biomolecules-09-00138" ref-type="bibr">89</xref>,<xref rid="B97-biomolecules-09-00138" ref-type="bibr">97</xref>], <italic>Nigella sativa</italic> EO [<xref rid="B78-biomolecules-09-00138" ref-type="bibr">78</xref>], and of the isolated terpenes triptolide [<xref rid="B41-biomolecules-09-00138" ref-type="bibr">41</xref>,<xref rid="B65-biomolecules-09-00138" ref-type="bibr">65</xref>,<xref rid="B71-biomolecules-09-00138" ref-type="bibr">71</xref>,<xref rid="B73-biomolecules-09-00138" ref-type="bibr">73</xref>], sericoside [<xref rid="B72-biomolecules-09-00138" ref-type="bibr">72</xref>], thymol [<xref rid="B10-biomolecules-09-00138" ref-type="bibr">10</xref>] and oleanoic and ursolic acids [<xref rid="B53-biomolecules-09-00138" ref-type="bibr">53</xref>], as well as the wound healing properties of <italic>Syzygium aromaticum</italic> EO [<xref rid="B83-biomolecules-09-00138" ref-type="bibr">83</xref>], <italic>Melaleuca alternifolia</italic> EO [<xref rid="B91-biomolecules-09-00138" ref-type="bibr">91</xref>], triterpenes from <italic>Centella asiatica</italic> extract [<xref rid="B85-biomolecules-09-00138" ref-type="bibr">85</xref>], madecassoside [<xref rid="B105-biomolecules-09-00138" ref-type="bibr">105</xref>], asiaticoside [<xref rid="B48-biomolecules-09-00138" ref-type="bibr">48</xref>], astragaloside IV [<xref rid="B59-biomolecules-09-00138" ref-type="bibr">59</xref>], and hyperforin [<xref rid="B11-biomolecules-09-00138" ref-type="bibr">11</xref>]. Also, the nanoencapsulation of the well-established taxane antineoplastic drugs paclitaxel [<xref rid="B14-biomolecules-09-00138" ref-type="bibr">14</xref>] and docetaxel [<xref rid="B13-biomolecules-09-00138" ref-type="bibr">13</xref>,<xref rid="B35-biomolecules-09-00138" ref-type="bibr">35</xref>] were studied for topical administration.</p><p>The systems can be divided according to their composition of polymers and lipids [<xref rid="B21-biomolecules-09-00138" ref-type="bibr">21</xref>]. Polymer-based systems can be constituted by natural, synthetic, and semisynthetic polymers and comprise systems such as nanocapsules (NC), nanoparticles (NP), nanofibers (NF), and nanogels (NG). On the other hand, the lipid-based systems, namely, nanoemulsions (NE), liposomes (LS), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and vesicular systems (VS) which comprehend ethosomes, phytosomes, niosomes, glycerosomes, and invasomes (IV) [<xref rid="B106-biomolecules-09-00138" ref-type="bibr">106</xref>], are formed by lipids [<xref rid="B104-biomolecules-09-00138" ref-type="bibr">104</xref>]. In addition, molecular complexation of terpenes with cyclodextrins is reported in the literature as a strategy for essential oil and natural products nanoencapsulation [<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B107-biomolecules-09-00138" ref-type="bibr">107</xref>]. </p><p>Encapsulation in nanometric systems is widely described in the literature as an approach to overcome many disadvantages concerning essential oils by providing protection against environmental factors that can cause chemical degradation and avoiding volatilization of EO components. In addition, nanoencapsulation can improve the bioavailability, allow controlled drug release, and enable the passage of the bioactive compounds through biological barriers [<xref rid="B21-biomolecules-09-00138" ref-type="bibr">21</xref>]. Patel et al. [<xref rid="B62-biomolecules-09-00138" ref-type="bibr">62</xref>] compared the cutaneous permeation of the sesquiterpene Hurpezine A from transdermal gels after encapsulation in three different systems, i.e., microemulsion (ME), SLN, and NLC, and the in vivo activity in an experimental mice model of induced amnesia. The ME formulation presented the highest cumulative permeated amounts, followed by NLC and SLN. The in vivo experiments presented no significant difference between the three formulations, but positive outcomes when compared to the negative control. In other study of comparison between different nanostructured systems, Flores et al. [<xref rid="B96-biomolecules-09-00138" ref-type="bibr">96</xref>] investigated nanocapsule suspensions and nanoemulsions containing tea tree oil against in in vitro onychomycosis models. Although both nanometric systems presented better antifungal activity compared to the coarse emulsion containing tea tree oil, the nanocapsule formulation was more effective against the microorganism. This may be attributed to the polymer barrier that prevents the volatilization of bioactive compounds as well as the capacity of the aqueous suspension to hydrate the tissue and therefore enhance the penetration of nanostructures. </p><p>Also, the complexation with cyclodextrins can be an interesting alternative, since it is reported to provide protection against environmental factors, improve stability, avoid volatilization of EO components, improve oral bioavailability, and reduce mucosal irritation [<xref rid="B23-biomolecules-09-00138" ref-type="bibr">23</xref>]. In addition, cyclodextrins are described as safe options to enhance the permeation of molecules through the skin and mucosae [<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B15-biomolecules-09-00138" ref-type="bibr">15</xref>,<xref rid="B108-biomolecules-09-00138" ref-type="bibr">108</xref>]. The complexation of essential oils and isolated terpenes with cyclodextrins has been reported in the literature and reviewed [<xref rid="B23-biomolecules-09-00138" ref-type="bibr">23</xref>,<xref rid="B109-biomolecules-09-00138" ref-type="bibr">109</xref>,<xref rid="B110-biomolecules-09-00138" ref-type="bibr">110</xref>]; however, the majority of investigations concerning complexes between cyclodextrins and essential oils or isolated terpenes for pharmaceutical applications are limited to oral administration, with few studies focusing on topical administration, and no reviews found in the literature covering this subject specifically. Rode et al. [<xref rid="B72-biomolecules-09-00138" ref-type="bibr">72</xref>] studied the influence of cyclodextrin complexation on the percutaneous penetration in pig skin of the triterpenoid sericoside from a <italic>Terminalia sericea</italic> extract. The formulation containing the sericoside from the extract complexed with &#x003b3;-cyclodextrin increased the percutaneous penetration 2.6 times when compared to an ethanolic solution of sericoside.</p><p>As illustrated in <xref ref-type="fig" rid="biomolecules-09-00138-f005">Figure 5</xref>, a variety of different nanostructured systems are used in the encapsulation of EO and terpenes. It can be noticed that lipid-based nanosystems are used in 67% of the formulations reported, which may be attributed to their low toxicity.</p><p>Although various preparation techniques of nanostructured systems are extensively described in the literature [<xref rid="B1-biomolecules-09-00138" ref-type="bibr">1</xref>,<xref rid="B2-biomolecules-09-00138" ref-type="bibr">2</xref>,<xref rid="B104-biomolecules-09-00138" ref-type="bibr">104</xref>], it is important to pay attention to the preparation technique in terms on its influence on EO/terpene stability, because of their sensitivity to heat and pressure. In this context, the quantification of chemical markers of EO or terpenes is essential, especially in cases where they play a role as bioactive compounds, in order to ensure the integrity of EO/terpene content in the final formulation and, thus, the safety and efficacy of the final product [<xref rid="B104-biomolecules-09-00138" ref-type="bibr">104</xref>].</p></sec><sec id="sec3dot2dot2-biomolecules-09-00138"><title>3.2.2. Terpenes as Excipients in Formulations for Topical Administration</title><p>Transdermal drug delivery represents a convenient route of administration for systemic action due to its non-invasive characteristic [<xref rid="B102-biomolecules-09-00138" ref-type="bibr">102</xref>,<xref rid="B111-biomolecules-09-00138" ref-type="bibr">111</xref>]. However, it is limited by the ability of the drug to permeate through the skin layers, especially the stratum corneum (SC). The use of penetration enhancers is a promising strategy to broaden the range of drugs eligible for transdermal delivery [<xref rid="B112-biomolecules-09-00138" ref-type="bibr">112</xref>]. </p><p>Permeation enhancers are used as excipients in formulations and are capable of facilitating the passage of a drug through the skin. Besides their biological activities, essential oils and isolated terpenes have been described as promising permeation enhancers for transdermal drug delivery. They can enhance the passage of drugs through the skin by interacting with stratum corneum lipids and modifying the solubility characteristics of these lipids, facilitating drug partitioning towards deeper layers of the skin [<xref rid="B7-biomolecules-09-00138" ref-type="bibr">7</xref>,<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>,<xref rid="B15-biomolecules-09-00138" ref-type="bibr">15</xref>,<xref rid="B102-biomolecules-09-00138" ref-type="bibr">102</xref>]. Furthermore, terpenes are considered safer than other permeation enhancers from a toxicological point of view, with some terpenes being included in the list of Generally Recognized as Safe (GRAS) compounds from the US FDA (United States Food and Drug Administration) [<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>].</p><p>The nanostructured systems in which terpenes are used as excipients are illustrated in <xref ref-type="fig" rid="biomolecules-09-00138-f006">Figure 6</xref>. The majority of systems are based on vesicular structures (LS, I,V and permeation-enhancing vehicles (PEV)), with the invasomes representing 27% of the nanostructured systems reported, followed by liposomes and nanoemulsions (20%).</p><p>Invasomes (also found in the literature as invasosomes) are special drug delivery systems that contain terpenes and are the most recurrent among the formulations of nanosystems using terpenes as excipients (<xref ref-type="fig" rid="biomolecules-09-00138-f006">Figure 6</xref>). They are, by definition, vesicular systems consisting of terpenes, ethanol, and phospholipids as fundamental raw materials and present elasticity and deformability, which favors penetration across skin layers, and thus they work as penetration-enhancing vehicles [<xref rid="B113-biomolecules-09-00138" ref-type="bibr">113</xref>]. According to the data presented in <xref rid="biomolecules-09-00138-t001" ref-type="table">Table 1</xref> and <xref rid="biomolecules-09-00138-t002" ref-type="table">Table 2</xref>, the terpenes used in the formulation of invasomes are limonene, cineole, fenchone, citral, and beta-citronellene; all of them are monoterpenes or monoterpenoids (<xref ref-type="fig" rid="biomolecules-09-00138-f007">Figure 7</xref>). </p><p>Kamran et al. [<xref rid="B45-biomolecules-09-00138" ref-type="bibr">45</xref>] studied the preparation of invasomes using beta-citronellene as a permeation enhancer for transdermal delivery of the antihypertensive olmesartan and observed an increase in the bioavailability of olmesartan from invasomes in Wistar rats compared to the control. Incorporation of isradipine, also an antihypertensive agent, in invasomes containing beta-citronellene was investigated by Qadri et al. [<xref rid="B42-biomolecules-09-00138" ref-type="bibr">42</xref>], who showed a decrease of 20% of blood pressure in rats. The permeation of rhodamine B invasomes through rat skin was evaluated by confocal laser spectroscopy, and fluorescence was detected at a depth of 171.18 mm in the skin. A series of studies focused on the encapsulation of temoporfin in invasomes, aiming to improve its penetration through the skin using several different proportions of cineole, citral, and d-limonene. The findings indicated that the optimal amount of terpenes in formulations should be 1% (v/v), and the formulation containing 1% of cineole alone led to higher permeation of the drug to deeper layers of the skin compared to mixtures of the three terpenes in varied proportions and limonene and citral alone [<xref rid="B68-biomolecules-09-00138" ref-type="bibr">68</xref>,<xref rid="B69-biomolecules-09-00138" ref-type="bibr">69</xref>,<xref rid="B70-biomolecules-09-00138" ref-type="bibr">70</xref>]. El-Nabarawi et al. [<xref rid="B25-biomolecules-09-00138" ref-type="bibr">25</xref>] prepared dapsone-loaded invasomes for acne treatment, containing different terpenes (limonene, cineole, citral, or fenchone) in varied concentrations in a full factorial design study and compared drug deposition in vivo of optimized formulations with dapsone solution, finding a 2.5-fold increase in dapsone deposition with the invasomes formulation.</p></sec></sec><sec id="sec3dot3-biomolecules-09-00138"><title>3.3. Safety of Essential Oils and Terpenes in Topical Administration</title><p>One important concern is the safety of the use of essential oils and terpenes in topical formulations. Although a number of essential oils and terpenes are considered GRAS [<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>], few studies investigated the safety of these compounds in topical application. Lalko and Api [<xref rid="B114-biomolecules-09-00138" ref-type="bibr">114</xref>] investigated the skin irritancy of essential oils and their isolated compounds, concluding that, in many cases, there is a potential induction of sensibilization upon exposure to these compounds. Some terpenes, as described in previous sections of this review, are used as permeation enhancers in drug delivery systems. They are considered non-toxic, nonirritant, and, therefore, a safe option for permeation enhancement [<xref rid="B115-biomolecules-09-00138" ref-type="bibr">115</xref>].</p></sec><sec id="sec3dot4-biomolecules-09-00138"><title>3.4. Sustainability</title><p>In recent decades, the efforts to reduce the environmental impact of chemical compounds and develop green chemistry have been growing. Terpenes and essential oils comprise a renewable source of chemical compounds and have been already described in the literature as &#x0201c;greener&#x0201d; alternatives to pesticides [<xref rid="B116-biomolecules-09-00138" ref-type="bibr">116</xref>] and solvents [<xref rid="B117-biomolecules-09-00138" ref-type="bibr">117</xref>]. Concerning the preparation of nanostructured systems, essential oils and terpenes can be used as more sustainable additives, being able to substitute organic solvents in the preparation of nanocapsules [<xref rid="B118-biomolecules-09-00138" ref-type="bibr">118</xref>] and in the synthesis of metallic nanoparticles [<xref rid="B119-biomolecules-09-00138" ref-type="bibr">119</xref>]. Also, effort has been made for the development of essential oil extraction techniques with no or less solvent and energy use without quality loss [<xref rid="B120-biomolecules-09-00138" ref-type="bibr">120</xref>]. When observing the 12 principles of Green Chemistry [<xref rid="B121-biomolecules-09-00138" ref-type="bibr">121</xref>], it is possible to see that the use of terpenes and essential oils may have some positive effects, since, as aforementioned, they are renewable supplies and present low toxicity [<xref rid="B8-biomolecules-09-00138" ref-type="bibr">8</xref>]. Furthermore, in the development of new formulations containing essential oils and terpenes, the 12 principles (prevention, atom economy, less hazardous chemical synthesis, designing safer chemicals, safer solvents and auxiliaries, design for energy efficient, use of renewable feedstocks, reduce derivatives, catalysis, design for degradation, real-time analysis for pollution prevention, and inherently safer chemistry for accident prevention) should be respected, since, besides reducing the environmental impact of chemicals, they can also lead to lower costs of production [<xref rid="B122-biomolecules-09-00138" ref-type="bibr">122</xref>], which can balance out investments made in the development and implementation of sustainable alternatives.</p></sec></sec><sec id="sec4-biomolecules-09-00138"><title>4. Concluding Remarks</title><p>The interest in the development of nanostructured systems containing essential oils and terpenes designed for topical administration routes has been rising in recent years. The majority of the formulations employ EO and/or terpenes as active ingredients encapsulated in nanostructured systems as means to improve the physicochemical properties and/or achieve greater bioavailability and controlled release of drugs. On the other hand, a part of the studies also shows the growing interest in using terpenes as permeation-enhancer excipients in transdermal delivery systems, a promising strategy for efficient and noninvasive drug delivery to the skin deeper layers.</p><p>Terpenes and essential oils present a sustainable alternative as raw materials in the pharmaceutical field and thus a valuable source, giving the growing importance of &#x0201c;greener&#x0201d; chemistry. Many of them are considered GRAS; however, there is a lack of information concerning their safety in topical administration.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank CAPES and CNPq for their scholarships.</p></ack><app-group><app id="app1-biomolecules-09-00138"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2218-273X/9/4/138/s1">https://www.mdpi.com/2218-273X/9/4/138/s1</uri>, Table S1: Database search lines. </p><supplementary-material content-type="local-data" id="biomolecules-09-00138-s001"><media xlink:href="biomolecules-09-00138-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization&#x02014;all authors; Data curation&#x02014;S.P.d.M.; Formal analysis&#x02013;S.P.d.M. and L.S.K.; Methodology&#x02014;S.P.d.M. and L.S.K.; Supervision&#x02014;L.S.K.; Writing&#x02014;original draft&#x02014;S.P.d.M. and L.S.K.; Writing&#x02014;review &#x00026; editing&#x02014;all authors. </p></notes><notes><title>Funding</title><p>This study was financed in part by the &#x0201c;Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02013;Brasil&#x0201d; (CAPES). Finance Code 001. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-biomolecules-09-00138"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asbahani</surname><given-names>A.E.</given-names></name><name><surname>Miladi</surname><given-names>K.</given-names></name><name><surname>Badri</surname><given-names>W.</given-names></name><name><surname>Sala</surname><given-names>M.</given-names></name><name><surname>Addi</surname><given-names>E.H.A.</given-names></name><name><surname>Casabianca</surname><given-names>H.</given-names></name><name><surname>Mousadik</surname><given-names>A.E.</given-names></name><name><surname>Hartmann</surname><given-names>D.</given-names></name><name><surname>Jilale</surname><given-names>A.</given-names></name><name><surname>Renaud</surname><given-names>F.N.R.</given-names></name><etal/></person-group><article-title>Essential oils: From extraction to encapsulation</article-title><source>Int. J. Pharm.</source><year>2015</year><volume>483</volume><fpage>220</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.12.069</pub-id><?supplied-pmid 25683145?><pub-id pub-id-type="pmid">25683145</pub-id></element-citation></ref><ref id="B2-biomolecules-09-00138"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilia</surname><given-names>A.R.</given-names></name><name><surname>Guccione</surname><given-names>C.</given-names></name><name><surname>Isacchi</surname><given-names>B.</given-names></name><name><surname>Righeschi</surname><given-names>C.</given-names></name><name><surname>Firenzuoli</surname><given-names>F.</given-names></name><name><surname>Bergonzi</surname><given-names>M.C.</given-names></name></person-group><article-title>Essential oils loaded in nanosystems: A developing strategy for a successful therapeutic approach</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2014</year><volume>2014</volume><pub-id pub-id-type="doi">10.1155/2014/651593</pub-id><?supplied-pmid 24971152?><pub-id pub-id-type="pmid">24971152</pub-id></element-citation></ref><ref id="B3-biomolecules-09-00138"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majeed</surname><given-names>H.</given-names></name><name><surname>Bian</surname><given-names>Y.-Y.</given-names></name><name><surname>Ali</surname><given-names>B.</given-names></name><name><surname>Jamil</surname><given-names>A.</given-names></name><name><surname>Majeed</surname><given-names>U.</given-names></name><name><surname>Khan</surname><given-names>Q.F.</given-names></name><name><surname>Iqbal</surname><given-names>K.J.</given-names></name><name><surname>Shoemaker</surname><given-names>C.F.</given-names></name><name><surname>Fang</surname><given-names>Z.</given-names></name></person-group><article-title>Essential oil encapsulations: Uses, procedures, and trends</article-title><source>RSC Adv.</source><year>2015</year><volume>5</volume><fpage>58449</fpage><lpage>58463</lpage><pub-id pub-id-type="doi">10.1039/C5RA06556A</pub-id></element-citation></ref><ref id="B4-biomolecules-09-00138"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershenzon</surname><given-names>J.</given-names></name><name><surname>Dudareva</surname><given-names>N.</given-names></name></person-group><article-title>The function of terpene natural products in the natural world</article-title><source>Nat. Chem. Biol.</source><year>2007</year><volume>3</volume><fpage>408</fpage><pub-id pub-id-type="doi">10.1038/nchembio.2007.5</pub-id><?supplied-pmid 17576428?><pub-id pub-id-type="pmid">17576428</pub-id></element-citation></ref><ref id="B5-biomolecules-09-00138"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffei</surname><given-names>M.E.</given-names></name><name><surname>Gertsch</surname><given-names>J.</given-names></name><name><surname>Appendino</surname><given-names>G.</given-names></name></person-group><article-title>Plant volatiles: Production, function and pharmacology</article-title><source>Nat. Prod. Rep.</source><year>2011</year><volume>28</volume><fpage>1359</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1039/c1np00021g</pub-id><?supplied-pmid 21670801?><pub-id pub-id-type="pmid">21670801</pub-id></element-citation></ref><ref id="B6-biomolecules-09-00138"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turek</surname><given-names>C.</given-names></name><name><surname>Stintzing</surname><given-names>F.C.</given-names></name></person-group><article-title>Stability of Essential Oils: A Review</article-title><source>Compr. Rev. Food Sci. F</source><year>2013</year><volume>12</volume><fpage>40</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1111/1541-4337.12006</pub-id></element-citation></ref><ref id="B7-biomolecules-09-00138"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>A.</given-names></name><name><surname>Herman</surname><given-names>A.P.</given-names></name></person-group><article-title>Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: A review</article-title><source>J. Pharm. Pharmacol.</source><year>2014</year><volume>67</volume><fpage>473</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1111/jphp.12334</pub-id><pub-id pub-id-type="pmid">25557808</pub-id></element-citation></ref><ref id="B8-biomolecules-09-00138"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapra</surname><given-names>B.</given-names></name><name><surname>Jain</surname><given-names>S.</given-names></name><name><surname>Tiwary</surname><given-names>A.K.</given-names></name></person-group><article-title>Percutaneous Permeation Enhancement by Terpenes: Mechanistic View</article-title><source>AAPS J.</source><year>2008</year><volume>10</volume><fpage>120</fpage><pub-id pub-id-type="doi">10.1208/s12248-008-9012-0</pub-id><pub-id pub-id-type="pmid">18446512</pub-id></element-citation></ref><ref id="B9-biomolecules-09-00138"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamm</surname><given-names>S.</given-names></name><name><surname>Bleton</surname><given-names>J.</given-names></name><name><surname>Connan</surname><given-names>J.</given-names></name><name><surname>Tchapla</surname><given-names>A.</given-names></name></person-group><article-title>A chemical investigation by headspace SPME and GC&#x02013;MS of volatile and semi-volatile terpenes in various Olibanum samples</article-title><source>Phytochemistry</source><year>2005</year><volume>66</volume><fpage>1499</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2005.04.025</pub-id><pub-id pub-id-type="pmid">15922374</pub-id></element-citation></ref><ref id="B10-biomolecules-09-00138"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pivetta</surname><given-names>T.P.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>S.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>M.M.</given-names></name><name><surname>Carvalho</surname><given-names>T.</given-names></name><name><surname>Arruda</surname><given-names>C.</given-names></name><name><surname>Marcato</surname><given-names>P.D.</given-names></name></person-group><article-title>Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties</article-title><source>Colloids Surf. B Biointerfaces</source><year>2018</year><volume>164</volume><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.01.053</pub-id><pub-id pub-id-type="pmid">29413607</pub-id></element-citation></ref><ref id="B11-biomolecules-09-00138"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>H.</given-names></name><name><surname>Yonekawa</surname><given-names>J.</given-names></name><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>Furuya</surname><given-names>K.</given-names></name><name><surname>Sokabe</surname><given-names>M.</given-names></name></person-group><article-title>Hyperforin/HP-&#x003b2;-Cyclodextrin Enhances Mechanosensitive Ca<sup>2+</sup>Signaling in HaCaT Keratinocytes and in Atopic Skin Ex Vivo Which Accelerates Wound Healing</article-title><source>Biomed. Res. Int.</source><year>2017</year><volume>2017</volume><fpage>8701801</fpage><pub-id pub-id-type="doi">10.1155/2017/8701801</pub-id><pub-id pub-id-type="pmid">28210627</pub-id></element-citation></ref><ref id="B12-biomolecules-09-00138"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosta</surname><given-names>F.V.</given-names></name><name><surname>Andrade</surname><given-names>L.M.</given-names></name><name><surname>Mendes</surname><given-names>L.P.</given-names></name><name><surname>Anjos</surname><given-names>J.L.V.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name><name><surname>Marreto</surname><given-names>R.N.</given-names></name><name><surname>Lima</surname><given-names>E.M.</given-names></name><name><surname>Taveira</surname><given-names>S.F.</given-names></name></person-group><article-title>Paclitaxel-loaded lipid nanoparticles for topical application: The influence of oil content on lipid dynamic behavior, stability, and drug skin penetration</article-title><source>J. Nanopart. Res.</source><year>2014</year><volume>16</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s11051-014-2782-7</pub-id></element-citation></ref><ref id="B13-biomolecules-09-00138"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Joshi</surname><given-names>M.</given-names></name><name><surname>Garg</surname><given-names>T.</given-names></name><name><surname>Goyal</surname><given-names>A.K.</given-names></name><name><surname>Rath</surname><given-names>G.</given-names></name></person-group><article-title>Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2015</year><volume>43</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.3109/21691401.2014.885442</pub-id><pub-id pub-id-type="pmid">24621011</pub-id></element-citation></ref><ref id="B14-biomolecules-09-00138"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharadwaj</surname><given-names>R.</given-names></name><name><surname>Das</surname><given-names>P.J.</given-names></name><name><surname>Pal</surname><given-names>P.</given-names></name><name><surname>Mazumder</surname><given-names>B.</given-names></name></person-group><article-title>Topical delivery of paclitaxel for treatment of skin cancer</article-title><source>Drug Dev. Ind. Pharm.</source><year>2016</year><volume>42</volume><fpage>1482</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.3109/03639045.2016.1151028</pub-id><pub-id pub-id-type="pmid">26850463</pub-id></element-citation></ref><ref id="B15-biomolecules-09-00138"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>V.R.</given-names></name><name><surname>Kaur</surname><given-names>M.P.</given-names></name></person-group><article-title>Permeation Enhancers for Transdermal Drug Delivery</article-title><source>Drug Dev. Ind. Pharm.</source><year>2000</year><volume>26</volume><fpage>1131</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1081/DDC-100100984</pub-id><pub-id pub-id-type="pmid">11068686</pub-id></element-citation></ref><ref id="B16-biomolecules-09-00138"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>R.P.W.</given-names></name></person-group><article-title>ESSENTIAL OILS</article-title><source>Encyclopedia of Analytical Science</source><edition>2nd ed.</edition><person-group person-group-type="editor"><name><surname>Worsfold</surname><given-names>P.</given-names></name><name><surname>Townshend</surname><given-names>A.</given-names></name><name><surname>Poole</surname><given-names>C.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>2005</year><fpage>554</fpage><lpage>561</lpage></element-citation></ref><ref id="B17-biomolecules-09-00138"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmik</surname><given-names>D.</given-names></name><name><surname>Gopinath</surname><given-names>H.</given-names></name><name><surname>Kumar</surname><given-names>B.P.</given-names></name><name><surname>Duraivel</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>K.S.</given-names></name></person-group><article-title>Recent advances in novel topical drug delivery system</article-title><source>Pharma Innov.</source><year>2012</year><volume>1</volume><fpage>12</fpage></element-citation></ref><ref id="B18-biomolecules-09-00138"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>M.B.</given-names></name><name><surname>Martin</surname><given-names>G.P.</given-names></name><name><surname>Jones</surname><given-names>S.A.</given-names></name><name><surname>Akomeah</surname><given-names>F.K.</given-names></name></person-group><article-title>Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects</article-title><source>Drug Deliv.</source><year>2006</year><volume>13</volume><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1080/10717540500455975</pub-id><pub-id pub-id-type="pmid">16556569</pub-id></element-citation></ref><ref id="B19-biomolecules-09-00138"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilherme</surname><given-names>V.A.</given-names></name><name><surname>Ribeiro</surname><given-names>L.N.M.</given-names></name><name><surname>Tofoli</surname><given-names>G.R.</given-names></name><name><surname>Franz-Montan</surname><given-names>M.</given-names></name><name><surname>de Paula</surname><given-names>E.</given-names></name><name><surname>de Jesus</surname><given-names>M.B.</given-names></name></person-group><article-title>Current challenges and future of lipid nanoparticles formulations for topical drug application to oral mucosa, skin, and eye</article-title><source>Curr. Pharm. Des.</source><year>2017</year><volume>23</volume><fpage>6659</fpage><lpage>6675</lpage><pub-id pub-id-type="doi">10.2174/1381612823666171122103849</pub-id></element-citation></ref><ref id="B20-biomolecules-09-00138"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sezer</surname><given-names>A.D.</given-names></name><name><surname>Cevher</surname><given-names>E.</given-names></name></person-group><article-title>Topical drug delivery using chitosan nano- and microparticles</article-title><source>Expert Opin. Drug Deliv.</source><year>2012</year><volume>9</volume><fpage>1129</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1517/17425247.2012.702752</pub-id><pub-id pub-id-type="pmid">22769587</pub-id></element-citation></ref><ref id="B21-biomolecules-09-00138"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilia</surname><given-names>A.R.</given-names></name><name><surname>Piazzini</surname><given-names>V.</given-names></name><name><surname>Guccione</surname><given-names>C.</given-names></name><name><surname>Risaliti</surname><given-names>L.</given-names></name><name><surname>Asprea</surname><given-names>M.</given-names></name><name><surname>Capecchi</surname><given-names>G.</given-names></name><name><surname>Bergonzi</surname><given-names>M.C.</given-names></name></person-group><article-title>Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs</article-title><source>Planta Med.</source><year>2017</year><volume>83</volume><fpage>366</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1055/s-0043-102949</pub-id><pub-id pub-id-type="pmid">28178749</pub-id></element-citation></ref><ref id="B22-biomolecules-09-00138"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barua</surname><given-names>S.</given-names></name><name><surname>Mitragotri</surname><given-names>S.</given-names></name></person-group><article-title>Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects</article-title><source>Nano Today</source><year>2014</year><volume>9</volume><fpage>223</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.nantod.2014.04.008</pub-id><pub-id pub-id-type="pmid">25132862</pub-id></element-citation></ref><ref id="B23-biomolecules-09-00138"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>P.S.S.</given-names></name><name><surname>Lucchese</surname><given-names>A.M.</given-names></name><name><surname>Ara&#x000fa;jo-Filho</surname><given-names>H.G.</given-names></name><name><surname>Menezes</surname><given-names>P.P.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>A.A.S.</given-names></name><name><surname>Quintans-J&#x000fa;nior</surname><given-names>L.J.</given-names></name><name><surname>Quintans</surname><given-names>J.S.S.</given-names></name></person-group><article-title>Inclusion of terpenes in cyclodextrins: Preparation, characterization and pharmacological approaches</article-title><source>Carbohydr. Polym.</source><year>2016</year><volume>151</volume><fpage>965</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2016.06.040</pub-id><pub-id pub-id-type="pmid">27474645</pub-id></element-citation></ref><ref id="B24-biomolecules-09-00138"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saettone</surname><given-names>M.F.</given-names></name><name><surname>Burgalassi</surname><given-names>S.</given-names></name><name><surname>Giannaccini</surname><given-names>B.</given-names></name></person-group><article-title>Preparation and Evaluation in Rabbits of Topical Solutions Containing Forskolin</article-title><source>J. Ocul. Pharmacol. Ther.</source><year>1989</year><volume>5</volume><fpage>111</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1089/jop.1989.5.111</pub-id></element-citation></ref><ref id="B25-biomolecules-09-00138"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Nabarawi</surname><given-names>M.A.</given-names></name><name><surname>Shamma</surname><given-names>R.N.</given-names></name><name><surname>Farouk</surname><given-names>F.</given-names></name><name><surname>Nasralla</surname><given-names>S.M.</given-names></name></person-group><article-title>Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay</article-title><source>AAPS PharmSciTech</source><year>2018</year><volume>19</volume><fpage>2174</fpage><lpage>2184</lpage><pub-id pub-id-type="doi">10.1208/s12249-018-1025-0</pub-id><pub-id pub-id-type="pmid">29725903</pub-id></element-citation></ref><ref id="B26-biomolecules-09-00138"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Abuzinadah</surname><given-names>M.F.</given-names></name><name><surname>Alkreathy</surname><given-names>H.M.</given-names></name><name><surname>Banaganapalli</surname><given-names>B.</given-names></name><name><surname>Mujeeb</surname><given-names>M.</given-names></name></person-group><article-title>Ursolic acid rich ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-&#x003b1; and IL-1: Pharmacological and docking studies</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0193451</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0193451</pub-id><pub-id pub-id-type="pmid">29558494</pub-id></element-citation></ref><ref id="B27-biomolecules-09-00138"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Hafez</surname><given-names>S.M.</given-names></name><name><surname>Hathout</surname><given-names>R.M.</given-names></name><name><surname>Sammour</surname><given-names>O.A.</given-names></name></person-group><article-title>Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy</article-title><source>Colloids Surf. B Biointerfaces</source><year>2018</year><volume>167</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.03.051</pub-id><pub-id pub-id-type="pmid">29626721</pub-id></element-citation></ref><ref id="B28-biomolecules-09-00138"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Mo</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Tian</surname><given-names>W.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>S.</given-names></name></person-group><article-title>Microneedle-Assisted Percutaneous Delivery of Paeoniflorin-Loaded Ethosomes</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>3371</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23123371</pub-id></element-citation></ref><ref id="B29-biomolecules-09-00138"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Xin</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group><article-title>Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery</article-title><source>Int. J. Pharm.</source><year>2018</year><volume>552</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.10.006</pub-id><pub-id pub-id-type="pmid">30291959</pub-id></element-citation></ref><ref id="B30-biomolecules-09-00138"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>K.R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hwang</surname><given-names>G.</given-names></name><name><surname>Jung</surname><given-names>H.I.</given-names></name><name><surname>Koo</surname><given-names>H.</given-names></name><name><surname>Benoit</surname><given-names>D.S.W.</given-names></name></person-group><article-title>Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery</article-title><source>Nanoscale</source><year>2019</year><volume>11</volume><fpage>219</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1039/C8NR05784B</pub-id></element-citation></ref><ref id="B31-biomolecules-09-00138"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd</surname><given-names>E.</given-names></name><name><surname>Benson</surname><given-names>H.A.E.</given-names></name><name><surname>Roberts</surname><given-names>M.S.</given-names></name><name><surname>Grice</surname><given-names>J.E.</given-names></name></person-group><article-title>Follicular Penetration of Caffeine from Topically Applied Nanoemulsion Formulations Containing Penetration Enhancers: In vitro Human Skin Studies</article-title><source>Skin Pharmacol. Physiol.</source><year>2018</year><volume>31</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1159/000489857</pub-id><pub-id pub-id-type="pmid">30001555</pub-id></element-citation></ref><ref id="B32-biomolecules-09-00138"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>N.</given-names></name><name><surname>Ogata</surname><given-names>F.</given-names></name><name><surname>Otake</surname><given-names>H.</given-names></name><name><surname>Nakazawa</surname><given-names>Y.</given-names></name><name><surname>Kawasaki</surname><given-names>N.</given-names></name></person-group><article-title>Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment</article-title><source>Int. J. Nanomed.</source><year>2018</year><volume>13</volume><fpage>5215</fpage><lpage>5229</lpage><pub-id pub-id-type="doi">10.2147/IJN.S173216</pub-id></element-citation></ref><ref id="B33-biomolecules-09-00138"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freag</surname><given-names>M.S.</given-names></name><name><surname>Saleh</surname><given-names>W.M.</given-names></name><name><surname>Abdallah</surname><given-names>O.Y.</given-names></name></person-group><article-title>Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: Ex-vivo mucopenetration and in-vivo pharmacokinetic assessments</article-title><source>Carbohydr. Polym.</source><year>2018</year><volume>188</volume><fpage>108</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2018.01.095</pub-id><pub-id pub-id-type="pmid">29525146</pub-id></element-citation></ref><ref id="B34-biomolecules-09-00138"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>K.</given-names></name><name><surname>Aqil</surname><given-names>M.</given-names></name><name><surname>Imam</surname><given-names>S.S.</given-names></name><name><surname>Ahad</surname><given-names>A.</given-names></name><name><surname>Moolakkadath</surname><given-names>T.</given-names></name><name><surname>Sultana</surname><given-names>Y.</given-names></name><name><surname>Mujeeb</surname><given-names>M.</given-names></name></person-group><article-title>Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>106</volume><fpage>1578</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.127</pub-id><pub-id pub-id-type="pmid">30119233</pub-id></element-citation></ref><ref id="B35-biomolecules-09-00138"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaccorso</surname><given-names>A.</given-names></name><name><surname>Musumeci</surname><given-names>T.</given-names></name><name><surname>Carbone</surname><given-names>C.</given-names></name><name><surname>Vicari</surname><given-names>L.</given-names></name><name><surname>Lauro</surname><given-names>M.R.</given-names></name><name><surname>Puglisi</surname><given-names>G.</given-names></name></person-group><article-title>Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery</article-title><source>Pharm. Dev. Technol.</source><year>2018</year><volume>23</volume><fpage>265</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1080/10837450.2017.1287731</pub-id><pub-id pub-id-type="pmid">28128676</pub-id></element-citation></ref><ref id="B36-biomolecules-09-00138"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lason</surname><given-names>E.</given-names></name><name><surname>Sikora</surname><given-names>E.</given-names></name><name><surname>Miastkowska</surname><given-names>M.</given-names></name><name><surname>Escribano</surname><given-names>E.</given-names></name><name><surname>Garcia-Celma</surname><given-names>M.J.</given-names></name><name><surname>Solans</surname><given-names>C.</given-names></name><name><surname>Llinas</surname><given-names>M.</given-names></name><name><surname>Ogonowski</surname><given-names>J.</given-names></name></person-group><article-title>NLCs as a potential carrier system for transdermal delivery of forskolin</article-title><source>Acta Biochim. Pol.</source><year>2018</year><volume>65</volume><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.18388/abp.2018_2554</pub-id><pub-id pub-id-type="pmid">30212592</pub-id></element-citation></ref><ref id="B37-biomolecules-09-00138"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Fei</surname><given-names>Y.R.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>H.S.</given-names></name><name><surname>Mu</surname><given-names>C.F.</given-names></name><name><surname>Li</surname><given-names>F.Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.S.</given-names></name></person-group><article-title>Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride</article-title><source>Int. J. Pharm.</source><year>2017</year><volume>533</volume><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2017.09.059</pub-id><pub-id pub-id-type="pmid">28943208</pub-id></element-citation></ref><ref id="B38-biomolecules-09-00138"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Feng</surname><given-names>N.</given-names></name></person-group><article-title>Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: Optimization, characterization, and evaluation in vitro and in vivo</article-title><source>Int. J. Nanomed.</source><year>2017</year><volume>12</volume><fpage>3521</fpage><lpage>3532</lpage><pub-id pub-id-type="doi">10.2147/IJN.S135749</pub-id></element-citation></ref><ref id="B39-biomolecules-09-00138"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duangjit</surname><given-names>S.</given-names></name><name><surname>Nimcharoenwan</surname><given-names>T.</given-names></name><name><surname>Chomya</surname><given-names>N.</given-names></name><name><surname>Locharoenrat</surname><given-names>N.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name></person-group><article-title>Computational design strategy: An approach to enhancing the transdermal delivery of optimal capsaicin-loaded transinvasomes</article-title><source>Drug Dev. Ind. Pharm.</source><year>2017</year><volume>43</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1080/03639045.2016.1220575</pub-id><pub-id pub-id-type="pmid">27487326</pub-id></element-citation></ref><ref id="B40-biomolecules-09-00138"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangsimawong</surname><given-names>W.</given-names></name><name><surname>Obata</surname><given-names>Y.</given-names></name><name><surname>Opanasopit</surname><given-names>P.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name></person-group><article-title>Enhancement of Galantamine HBr Skin Permeation Using Sonophoresis and Limonene-Containing PEGylated Liposomes</article-title><source>AAPS PharmSciTech</source><year>2017</year><volume>19</volume><fpage>1093</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1208/s12249-017-0921-z</pub-id><pub-id pub-id-type="pmid">29168128</pub-id></element-citation></ref><ref id="B41-biomolecules-09-00138"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name></person-group><article-title>Development of triptolide-nanoemulsion gels for percutaneous administration: Physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics</article-title><source>J. Nanobiotechnol.</source><year>2017</year><volume>15</volume><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/s12951-017-0323-0</pub-id></element-citation></ref><ref id="B42-biomolecules-09-00138"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qadri</surname><given-names>G.R.</given-names></name><name><surname>Ahad</surname><given-names>A.</given-names></name><name><surname>Aqil</surname><given-names>M.</given-names></name><name><surname>Imam</surname><given-names>S.S.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name></person-group><article-title>Invasomes of isradipine for enhanced transdermal delivery against hypertension: Formulation, characterization, and in vivo pharmacodynamic study</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2017</year><volume>45</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.3109/21691401.2016.1138486</pub-id><pub-id pub-id-type="pmid">26829018</pub-id></element-citation></ref><ref id="B43-biomolecules-09-00138"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>G.F.D.</given-names></name><name><surname>Vieira-Neto</surname><given-names>A.E.</given-names></name><name><surname>da Costa</surname><given-names>F.N.</given-names></name><name><surname>e Silva</surname><given-names>A.R.A.</given-names></name><name><surname>Campos</surname><given-names>A.R.</given-names></name></person-group><article-title>Antinociceptive effect of (-)-&#x003b1;-bisabolol in nanocapsules</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>91</volume><fpage>946</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.05.024</pub-id><pub-id pub-id-type="pmid">28514833</pub-id></element-citation></ref><ref id="B44-biomolecules-09-00138"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelsamie</surname><given-names>S.M.</given-names></name><name><surname>Kamel</surname><given-names>A.O.</given-names></name><name><surname>Sammour</surname><given-names>O.A.</given-names></name><name><surname>Ibrahim</surname><given-names>S.M.</given-names></name></person-group><article-title>Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation</article-title><source>Eur. J. Pharm. Sci.</source><year>2016</year><volume>88</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2016.04.004</pub-id><pub-id pub-id-type="pmid">27072432</pub-id></element-citation></ref><ref id="B45-biomolecules-09-00138"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamran</surname><given-names>M.</given-names></name><name><surname>Ahad</surname><given-names>A.</given-names></name><name><surname>Aqil</surname><given-names>M.</given-names></name><name><surname>Imam</surname><given-names>S.S.</given-names></name><name><surname>Sultana</surname><given-names>Y.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name></person-group><article-title>Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment</article-title><source>Int. J. Pharm.</source><year>2016</year><volume>505</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.03.030</pub-id><pub-id pub-id-type="pmid">27005906</pub-id></element-citation></ref><ref id="B46-biomolecules-09-00138"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogoll</surname><given-names>K.</given-names></name><name><surname>Stein</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Arnold</surname><given-names>P.</given-names></name><name><surname>Peters</surname><given-names>T.</given-names></name><name><surname>Schild</surname><given-names>H.</given-names></name><name><surname>Radsak</surname><given-names>M.</given-names></name><name><surname>Langguth</surname><given-names>P.</given-names></name></person-group><article-title>Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization</article-title><source>Cell. Immunol.</source><year>2016</year><volume>308</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2016.06.001</pub-id><pub-id pub-id-type="pmid">27318760</pub-id></element-citation></ref><ref id="B47-biomolecules-09-00138"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name></person-group><article-title>Tea tree oil nanoemulsions for inhalation therapies of bacterial and fungal pneumonia</article-title><source>Colloids Surf. B Biointerfaces</source><year>2016</year><volume>141</volume><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.02.017</pub-id><pub-id pub-id-type="pmid">26895502</pub-id></element-citation></ref><ref id="B48-biomolecules-09-00138"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name></person-group><article-title>Preparation of asiaticoside-loaded coaxially electrospinning nanofibers and their effect on deep partial-thickness burn injury</article-title><source>Biomed. Pharmacother.</source><year>2016</year><volume>83</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.06.016</pub-id><pub-id pub-id-type="pmid">27470547</pub-id></element-citation></ref><ref id="B49-biomolecules-09-00138"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>C.Y.</given-names></name><name><surname>Xu</surname><given-names>P.H.</given-names></name><name><surname>Shen</surname><given-names>B.D.</given-names></name><name><surname>Min</surname><given-names>H.Y.</given-names></name><name><surname>Li</surname><given-names>X.R.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>H.L.</given-names></name></person-group><article-title>Nanogel for dermal application of the triterpenoids isolated from Ganoderma lucidum (GLT) for frostbite treatment</article-title><source>Drug Deliv.</source><year>2016</year><volume>23</volume><fpage>610</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.3109/10717544.2014.929756</pub-id><pub-id pub-id-type="pmid">24963753</pub-id></element-citation></ref><ref id="B50-biomolecules-09-00138"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Rai</surname><given-names>S.M.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name></person-group><article-title>Hydrogel Microparticles as an Emerging Tool in Pharmaceutical Field: A Review</article-title><source>Adv. Polym. Technol.</source><year>2016</year><volume>35</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1002/adv.21535</pub-id></element-citation></ref><ref id="B51-biomolecules-09-00138"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamal</surname><given-names>M.</given-names></name><name><surname>Imam</surname><given-names>S.S.</given-names></name><name><surname>Aqil</surname><given-names>M.</given-names></name><name><surname>Amir</surname><given-names>M.</given-names></name><name><surname>Mir</surname><given-names>S.R.</given-names></name><name><surname>Mujeeb</surname><given-names>M.</given-names></name></person-group><article-title>Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems</article-title><source>Int. Immunopharmacol.</source><year>2015</year><volume>29</volume><fpage>361</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.10.029</pub-id><pub-id pub-id-type="pmid">26545446</pub-id></element-citation></ref><ref id="B52-biomolecules-09-00138"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horev</surname><given-names>B.</given-names></name><name><surname>Klein</surname><given-names>M.I.</given-names></name><name><surname>Hwang</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Koo</surname><given-names>H.</given-names></name><name><surname>Benoit</surname><given-names>D.S.W.</given-names></name></person-group><article-title>pH-activated Nanoparticles for Controlled Topical Delivery of Farnesol to Disrupt Oral Biofilm Virulence</article-title><source>ACS Nano</source><year>2015</year><volume>9</volume><fpage>2390</fpage><lpage>2404</lpage><pub-id pub-id-type="doi">10.1021/nn507170s</pub-id><pub-id pub-id-type="pmid">25661192</pub-id></element-citation></ref><ref id="B53-biomolecules-09-00138"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarado</surname><given-names>H.</given-names></name><name><surname>Abrego</surname><given-names>G.</given-names></name><name><surname>Souto</surname><given-names>E.B.</given-names></name><name><surname>Gardu&#x000f1;o-Ramirez</surname><given-names>M.L.</given-names></name><name><surname>Clar&#x000e9;s</surname><given-names>B.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>M.</given-names></name><name><surname>Calpena</surname><given-names>A.</given-names></name></person-group><article-title>Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization</article-title><source>Colloids Surf. B Biointerfaces</source><year>2015</year><volume>130</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.03.062</pub-id><?supplied-pmid 25899842?><pub-id pub-id-type="pmid">25899842</pub-id></element-citation></ref><ref id="B54-biomolecules-09-00138"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W.-C.</given-names></name><name><surname>Chiang</surname><given-names>B.-H.</given-names></name><name><surname>Huang</surname><given-names>D.-W.</given-names></name><name><surname>Li</surname><given-names>P.-H.</given-names></name></person-group><article-title>Skin permeation of d-limonene-based nanoemulsions as a transdermal carrier prepared by ultrasonic emulsification</article-title><source>Ultrason. Sonochem.</source><year>2014</year><volume>21</volume><fpage>826</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.ultsonch.2013.10.013</pub-id><pub-id pub-id-type="pmid">24183592</pub-id></element-citation></ref><ref id="B55-biomolecules-09-00138"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangsimawong</surname><given-names>W.</given-names></name><name><surname>Opanasopit</surname><given-names>P.</given-names></name><name><surname>Rojanarata</surname><given-names>T.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name></person-group><article-title>Terpene-Containing PEGylated Liposomes as Transdermal Carriers of a Hydrophilic Compound</article-title><source>Boil. Pharm. Bull.</source><year>2014</year><volume>37</volume><fpage>1936</fpage><lpage>1943</lpage><pub-id pub-id-type="doi">10.1248/bpb.b14-00535</pub-id></element-citation></ref><ref id="B56-biomolecules-09-00138"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charoenputtakun</surname><given-names>P.</given-names></name><name><surname>Pamornpathomkul</surname><given-names>B.</given-names></name><name><surname>Opanasopit</surname><given-names>P.</given-names></name><name><surname>Rojanarata</surname><given-names>T.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name></person-group><article-title>Terpene Composited Lipid Nanoparticles for Enhanced Dermal Delivery of All-trans-Retinoic Acids</article-title><source>Boil. Pharm. Bull.</source><year>2014</year><volume>37</volume><fpage>1139</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1248/bpb.b14-00015</pub-id></element-citation></ref><ref id="B57-biomolecules-09-00138"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehelean</surname><given-names>C.A.</given-names></name><name><surname>Feflea</surname><given-names>S.</given-names></name><name><surname>Gheorgheosu</surname><given-names>D.</given-names></name><name><surname>Ganta</surname><given-names>S.</given-names></name><name><surname>Cimpean</surname><given-names>A.M.</given-names></name><name><surname>Muntean</surname><given-names>D.</given-names></name><name><surname>Amiji</surname><given-names>M.M.</given-names></name></person-group><article-title>Anti-Angiogenic and Anti-Cancer Evaluation of Betulin Nanoemulsion in Chicken Chorioallantoic Membrane and Skin Carcinoma in Balb/c Mice</article-title><source>J. Biomed. Nanotechnol.</source><year>2013</year><volume>9</volume><fpage>577</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1166/jbn.2013.1563</pub-id><pub-id pub-id-type="pmid">23621016</pub-id></element-citation></ref><ref id="B58-biomolecules-09-00138"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandig</surname><given-names>A.G.</given-names></name><name><surname>Campmany</surname><given-names>A.C.</given-names></name><name><surname>Campos</surname><given-names>F.F.</given-names></name><name><surname>Villena</surname><given-names>M.M.</given-names></name><name><surname>Naveros</surname><given-names>B.C.</given-names></name></person-group><article-title>Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: Development, characterization and in vivo evaluation</article-title><source>Colloids Surf. B Biointerfaces</source><year>2013</year><volume>103</volume><fpage>558</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2012.10.061</pub-id><pub-id pub-id-type="pmid">23261580</pub-id></element-citation></ref><ref id="B59-biomolecules-09-00138"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>L.-H.</given-names></name><name><surname>Shan</surname><given-names>Y.-H.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Q.-M.</given-names></name><name><surname>Liang</surname><given-names>W.-Q.</given-names></name><name><surname>Gao</surname><given-names>J.-Q.</given-names></name></person-group><article-title>Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery</article-title><source>Int. J. Pharm.</source><year>2013</year><volume>447</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.02.054</pub-id><pub-id pub-id-type="pmid">23500766</pub-id></element-citation></ref><ref id="B60-biomolecules-09-00138"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subongkot</surname><given-names>T.</given-names></name><name><surname>Wonglertnirant</surname><given-names>N.</given-names></name><name><surname>Songprakhon</surname><given-names>P.</given-names></name><name><surname>Rojanarata</surname><given-names>T.</given-names></name><name><surname>Opanasopit</surname><given-names>P.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name></person-group><article-title>Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy</article-title><source>Int. J. Pharm.</source><year>2013</year><volume>441</volume><fpage>151</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.12.003</pub-id><pub-id pub-id-type="pmid">23247017</pub-id></element-citation></ref><ref id="B61-biomolecules-09-00138"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>N.B.</given-names></name><name><surname>Migliaccio</surname><given-names>V.</given-names></name><name><surname>Facundo</surname><given-names>V.A.</given-names></name><name><surname>Ciancaglini</surname><given-names>P.</given-names></name><name><surname>Stabeli</surname><given-names>R.G.</given-names></name><name><surname>Nicolete</surname><given-names>R.</given-names></name><name><surname>Silva-Jardim</surname><given-names>I.</given-names></name></person-group><article-title>Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: Macrophage as target cell</article-title><source>Exp. Parasitol.</source><year>2013</year><volume>135</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2013.07.022</pub-id><pub-id pub-id-type="pmid">23933281</pub-id></element-citation></ref><ref id="B62-biomolecules-09-00138"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>P.A.</given-names></name><name><surname>Patil</surname><given-names>S.C.</given-names></name><name><surname>Kalaria</surname><given-names>D.R.</given-names></name><name><surname>Kalia</surname><given-names>Y.N.</given-names></name><name><surname>Patravale</surname><given-names>V.B.</given-names></name></person-group><article-title>Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A</article-title><source>Int. J. Pharm.</source><year>2013</year><volume>446</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.02.014</pub-id><pub-id pub-id-type="pmid">23410989</pub-id></element-citation></ref><ref id="B63-biomolecules-09-00138"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.-H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name></person-group><article-title>Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers</article-title><source>Int. J. Nanomed.</source><year>2012</year><volume>7</volume><fpage>3023</fpage><lpage>3033</lpage></element-citation></ref><ref id="B64-biomolecules-09-00138"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolino</surname><given-names>D.</given-names></name><name><surname>Cosco</surname><given-names>D.</given-names></name><name><surname>Cilurzo</surname><given-names>F.</given-names></name><name><surname>Trapasso</surname><given-names>E.</given-names></name><name><surname>Morittu</surname><given-names>V.M.</given-names></name><name><surname>Celia</surname><given-names>C.</given-names></name><name><surname>Fresta</surname><given-names>M.</given-names></name></person-group><article-title>Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles</article-title><source>J. Control.</source><year>2012</year><volume>162</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2012.05.050</pub-id><?supplied-pmid 22698941?><pub-id pub-id-type="pmid">22698941</pub-id></element-citation></ref><ref id="B65-biomolecules-09-00138"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.-G.</given-names></name><name><surname>Liu</surname><given-names>Y.-F.</given-names></name><name><surname>Gao</surname><given-names>T.-W.</given-names></name></person-group><article-title>Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model</article-title><source>J. Liposome Res.</source><year>2010</year><volume>20</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.3109/08982100903544144</pub-id><pub-id pub-id-type="pmid">20102297</pub-id></element-citation></ref><ref id="B66-biomolecules-09-00138"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J.-Y.</given-names></name></person-group><article-title>Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery</article-title><source>Int. J. Nanomed.</source><year>2010</year><volume>5</volume><fpage>117</fpage><pub-id pub-id-type="doi">10.2147/IJN.S9155</pub-id></element-citation></ref><ref id="B67-biomolecules-09-00138"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mura</surname><given-names>S.</given-names></name><name><surname>Manconi</surname><given-names>M.</given-names></name><name><surname>Sinico</surname><given-names>C.</given-names></name><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>Fadda</surname><given-names>A.M.</given-names></name></person-group><article-title>Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil</article-title><source>Int. J. Pharm.</source><year>2009</year><volume>380</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.06.040</pub-id><pub-id pub-id-type="pmid">19589377</pub-id></element-citation></ref><ref id="B68-biomolecules-09-00138"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic-Curic</surname><given-names>N.</given-names></name><name><surname>Gr&#x000e4;fe</surname><given-names>S.</given-names></name><name><surname>Albrecht</surname><given-names>V.</given-names></name><name><surname>Fahr</surname><given-names>A.</given-names></name></person-group><article-title>Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: A pilot study</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2008</year><volume>91</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2008.01.009</pub-id></element-citation></ref><ref id="B69-biomolecules-09-00138"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic-Curic</surname><given-names>N.</given-names></name><name><surname>Scheglmann</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>V.</given-names></name><name><surname>Fahr</surname><given-names>A.</given-names></name></person-group><article-title>Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies</article-title><source>J. Control.</source><year>2008</year><volume>127</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2007.12.013</pub-id></element-citation></ref><ref id="B70-biomolecules-09-00138"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic-Curic</surname><given-names>N.</given-names></name><name><surname>Scheglmann</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>V.</given-names></name><name><surname>Fahr</surname><given-names>A.</given-names></name></person-group><article-title>Development of different temoporfin-loaded invasomes&#x02014;Novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies</article-title><source>Colloids Surf. B Biointerfaces</source><year>2009</year><volume>70</volume><fpage>198</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2008.12.030</pub-id><pub-id pub-id-type="pmid">19188048</pub-id></element-citation></ref><ref id="B71-biomolecules-09-00138"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Lib</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Triptolide Loaded Solid Lipid Nanoparticle Hydrogel for Topical Application</article-title><source>Drug Dev. Ind. Pharm.</source><year>2005</year><volume>31</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1081/DDC-200047791</pub-id><pub-id pub-id-type="pmid">15773283</pub-id></element-citation></ref><ref id="B72-biomolecules-09-00138"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rode</surname><given-names>T.</given-names></name></person-group><article-title>Complex formation of sericoside with hydrophilic cyclodextrins: Improvement of solubility and skin penetration in topical emulsion-based formulations</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2003</year><volume>55</volume><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/S0939-6411(02)00194-7</pub-id><pub-id pub-id-type="pmid">12637096</pub-id></element-citation></ref><ref id="B73-biomolecules-09-00138"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>Z.</given-names></name></person-group><article-title>Solid lipid nanoparticle and microemulsion for topical delivery of triptolide</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2003</year><volume>56</volume><fpage>189</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/S0939-6411(03)00067-5</pub-id><pub-id pub-id-type="pmid">12957632</pub-id></element-citation></ref><ref id="B74-biomolecules-09-00138"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afifah</surname><given-names>S.N.</given-names></name><name><surname>Azhar</surname><given-names>S.</given-names></name><name><surname>Ashari</surname><given-names>S.E.</given-names></name><name><surname>Salim</surname><given-names>N.</given-names></name></person-group><article-title>Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment</article-title><source>Int. J. Nanomed.</source><year>2018</year><volume>13</volume><fpage>6465</fpage><lpage>6479</lpage></element-citation></ref><ref id="B75-biomolecules-09-00138"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barradas</surname><given-names>T.N.</given-names></name><name><surname>Senna</surname><given-names>J.P.</given-names></name><name><surname>Cardoso</surname><given-names>S.A.</given-names></name><name><surname>Silva</surname><given-names>K.G.D.E.</given-names></name><name><surname>Mansur</surname><given-names>C.R.E.</given-names></name></person-group><article-title>Formulation characterization and in vitro drug release of hydrogel-thickened nanoemulsions for topical delivery of 8-methoxypsoralen</article-title><source>Mater. Sci. Eng. C Mater. Biol. Appl.</source><year>2018</year><volume>92</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.msec.2018.06.049</pub-id><?supplied-pmid 30184748?><pub-id pub-id-type="pmid">30184748</pub-id></element-citation></ref><ref id="B76-biomolecules-09-00138"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>C.A.</given-names></name><name><surname>Gouv&#x000ea;a</surname><given-names>M.M.</given-names></name><name><surname>Antunes</surname><given-names>G.R.</given-names></name><name><surname>Freitas</surname><given-names>Z.M.F.</given-names></name><name><surname>Marques</surname><given-names>F.F.C.</given-names></name><name><surname>Ricci-Junior</surname><given-names>E.</given-names></name></person-group><article-title>Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin</article-title><source>Int. J. Pharm.</source><year>2018</year><volume>547</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.05.053</pub-id><?supplied-pmid 29800737?><pub-id pub-id-type="pmid">29800737</pub-id></element-citation></ref><ref id="B77-biomolecules-09-00138"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>N.</given-names></name><name><surname>Patel</surname><given-names>D.K.</given-names></name><name><surname>Rai</surname><given-names>V.K.</given-names></name><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Yadav</surname><given-names>N.P.</given-names></name></person-group><article-title>Development of Emulgel formulation for vaginal candidiasis: Pharmaceutical characterization, in vitro and in vivo evaluation</article-title><source>J. Drug Deliv. Sci. Technol.</source><year>2018</year><volume>48</volume><fpage>490</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.jddst.2018.10.013</pub-id></element-citation></ref><ref id="B78-biomolecules-09-00138"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alotaibi</surname><given-names>F.O.</given-names></name><name><surname>Mustafa</surname><given-names>G.</given-names></name><name><surname>Ahuja</surname><given-names>A.</given-names></name></person-group><article-title>Study of Enhanced Anti-Inflammatory Potential of Nigella Sativa in Topical Nanoformulation</article-title><source>Int. J. Pharm. Pharm. Sci.</source><year>2018</year><volume>10</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.22159/ijpps.2018v10i7.22966</pub-id></element-citation></ref><ref id="B79-biomolecules-09-00138"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barradas</surname><given-names>T.N.</given-names></name><name><surname>Senna</surname><given-names>J.P.</given-names></name><name><surname>Cardoso</surname><given-names>S.A.</given-names></name><name><surname>Nicoli</surname><given-names>S.</given-names></name><name><surname>Padula</surname><given-names>C.</given-names></name><name><surname>Santi</surname><given-names>P.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name><name><surname>Silva</surname><given-names>K.G.D.E.</given-names></name><name><surname>Mansur</surname><given-names>C.R.E.</given-names></name></person-group><article-title>Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2017</year><volume>116</volume><fpage>38</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2016.11.018</pub-id><pub-id pub-id-type="pmid">27867112</pub-id></element-citation></ref><ref id="B80-biomolecules-09-00138"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalita</surname><given-names>S.</given-names></name><name><surname>Kandimalla</surname><given-names>R.</given-names></name><name><surname>Devi</surname><given-names>B.</given-names></name><name><surname>Kalita</surname><given-names>B.</given-names></name><name><surname>Kalita</surname><given-names>K.</given-names></name><name><surname>Deka</surname><given-names>M.</given-names></name><name><surname>Kataki</surname><given-names>A.C.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Kotoky</surname><given-names>J.</given-names></name></person-group><article-title>Dual delivery of chloramphenicol and essential oil by poly-&#x003b5;-caprolactone-Pluronic nanocapsules to treat MRSA-Candida co-infected chronic burn wounds</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>1749</fpage><lpage>1758</lpage><pub-id pub-id-type="doi">10.1039/C6RA26561H</pub-id></element-citation></ref><ref id="B81-biomolecules-09-00138"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montenegro</surname><given-names>L.</given-names></name><name><surname>Pasquinucci</surname><given-names>L.</given-names></name><name><surname>Zappal&#x000e0;</surname><given-names>A.</given-names></name><name><surname>Chiechio</surname><given-names>S.</given-names></name><name><surname>Turnaturi</surname><given-names>R.</given-names></name><name><surname>Parenti</surname><given-names>C.</given-names></name></person-group><article-title>Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles</article-title><source>Pharmaceutics</source><year>2017</year><volume>9</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics9040048</pub-id></element-citation></ref><ref id="B82-biomolecules-09-00138"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navayan</surname><given-names>A.</given-names></name><name><surname>Moghimipour</surname><given-names>E.</given-names></name><name><surname>Khodayar</surname><given-names>M.J.</given-names></name><name><surname>Vazirianzadeh</surname><given-names>B.</given-names></name><name><surname>Siahpoosh</surname><given-names>A.</given-names></name><name><surname>Valizadeh</surname><given-names>M.</given-names></name><name><surname>Mansourzadeh</surname><given-names>Z.</given-names></name></person-group><article-title>Evaluation of the Mosquito Repellent Activity of Nano-sized Microemulsion of Eucalyptus globulus Essential Oil Against Culicinae</article-title><source>Jundishapur J. Nat. Pharm. Prod.</source><year>2017</year><volume>12</volume><pub-id pub-id-type="doi">10.5812/jjnpp.55626</pub-id></element-citation></ref><ref id="B83-biomolecules-09-00138"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>P.</given-names></name><name><surname>Ansari</surname><given-names>M.J.</given-names></name><name><surname>Anwer</surname><given-names>M.K.</given-names></name><name><surname>Raish</surname><given-names>M.</given-names></name><name><surname>Kamal</surname><given-names>Y.K.T.</given-names></name><name><surname>Shakeel</surname><given-names>F.</given-names></name></person-group><article-title>Wound healing effects of nanoemulsion containing clove essential oil</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2017</year><volume>45</volume><fpage>591</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.3109/21691401.2016.1163716</pub-id><?supplied-pmid 28211300?><pub-id pub-id-type="pmid">28211300</pub-id></element-citation></ref><ref id="B84-biomolecules-09-00138"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>P.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Mishra</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>D.K.</given-names></name><name><surname>Luqman</surname><given-names>S.</given-names></name><name><surname>Chanda</surname><given-names>D.</given-names></name><name><surname>Yadav</surname><given-names>N.P.</given-names></name></person-group><article-title>Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology</article-title><source>Drug Dev. Ind. Pharm.</source><year>2016</year><volume>42</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3109/03639045.2016.1141931</pub-id><?supplied-pmid 26821208?><pub-id pub-id-type="pmid">26325119</pub-id></element-citation></ref><ref id="B85-biomolecules-09-00138"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawatdee</surname><given-names>S.</given-names></name><name><surname>Choochuay</surname><given-names>K.</given-names></name><name><surname>Chanthorn</surname><given-names>W.</given-names></name><name><surname>Srichana</surname><given-names>T.</given-names></name></person-group><article-title>Evaluation of the topical spray containing Centella asiatica extract and its efficacy on excision wounds in rats</article-title><source>Acta Pharm.</source><year>2016</year><volume>66</volume><fpage>233</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1515/acph-2016-0018</pub-id><pub-id pub-id-type="pmid">27279066</pub-id></element-citation></ref><ref id="B86-biomolecules-09-00138"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname><given-names>M.A.</given-names></name><name><surname>Barros</surname><given-names>G.</given-names></name><name><surname>Queiroz</surname><given-names>D.B.</given-names></name><name><surname>Carvalho</surname><given-names>C.F.</given-names></name><name><surname>Gouvea</surname><given-names>J.</given-names></name><name><surname>Patrus</surname><given-names>L.</given-names></name><name><surname>Bannet</surname><given-names>M.</given-names></name><name><surname>Patrus</surname><given-names>D.</given-names></name><name><surname>Rego</surname><given-names>A.</given-names></name><name><surname>Silva</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Nanotechnology in Phytotherapy: Antiinflammatory Effect of a Nanostructured Thymol Gel from Lippia sidoides in Acute Periodontitis in Rats</article-title><source>Phytother. Res.</source><year>2016</year><volume>30</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1002/ptr.5516</pub-id><?supplied-pmid 26553130?><pub-id pub-id-type="pmid">26553130</pub-id></element-citation></ref><ref id="B87-biomolecules-09-00138"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafa</surname><given-names>D.M.</given-names></name><name><surname>El-Alim</surname><given-names>S.H.A.</given-names></name><name><surname>Asfour</surname><given-names>M.H.</given-names></name><name><surname>Al-Okbi</surname><given-names>S.Y.</given-names></name><name><surname>Mohamed</surname><given-names>D.A.</given-names></name><name><surname>Awad</surname><given-names>G.</given-names></name><name><surname>El-Alim</surname><given-names>S.A.</given-names></name></person-group><article-title>Transdermal nanoemulsions of Foeniculum vulgare Mill. essential oil: Preparation, characterization and evaluation of antidiabetic potential</article-title><source>J. Drug Deliv. Sci. Technol.</source><year>2015</year><volume>29</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.jddst.2015.06.021</pub-id></element-citation></ref><ref id="B88-biomolecules-09-00138"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldawsari</surname><given-names>H.M.</given-names></name><name><surname>Badr-Eldin</surname><given-names>S.M.</given-names></name><name><surname>Labib</surname><given-names>G.S.</given-names></name><name><surname>El-Kamel</surname><given-names>A.H.</given-names></name></person-group><article-title>Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: In vitro/in vivo evaluation</article-title><source>Int. J. Nanomed.</source><year>2015</year><volume>10</volume><fpage>893</fpage><lpage>902</lpage></element-citation></ref><ref id="B89-biomolecules-09-00138"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucca</surname><given-names>L.G.</given-names></name><name><surname>De Matos</surname><given-names>S.P.</given-names></name><name><surname>Borille</surname><given-names>B.T.</given-names></name><name><surname>Dias</surname><given-names>D.D.O.</given-names></name><name><surname>Teixeira</surname><given-names>H.F.</given-names></name><name><surname>Veiga</surname><given-names>V.F.</given-names></name><name><surname>Limberger</surname><given-names>R.P.</given-names></name><name><surname>Koester</surname><given-names>L.S.</given-names></name></person-group><article-title>Determination of &#x003b2;-caryophyllene skin permeation/retention from crude copaiba oil (<italic>Copaifera multijuga</italic> Hayne) and respective oil-based nanoemulsion using a novel HS-GC/MS method</article-title><source>J. Pharm. Biomed. Anal.</source><year>2015</year><volume>104</volume><fpage>144</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2014.11.013</pub-id><pub-id pub-id-type="pmid">25499655</pub-id></element-citation></ref><ref id="B90-biomolecules-09-00138"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castangia</surname><given-names>I.</given-names></name><name><surname>Manca</surname><given-names>M.L.</given-names></name><name><surname>Caddeo</surname><given-names>C.</given-names></name><name><surname>Maxia</surname><given-names>A.</given-names></name><name><surname>Murgia</surname><given-names>S.</given-names></name><name><surname>Pons</surname><given-names>R.</given-names></name><name><surname>Demurtas</surname><given-names>D.</given-names></name><name><surname>Pando</surname><given-names>D.</given-names></name><name><surname>Falconieri</surname><given-names>D.</given-names></name><name><surname>Peris</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>Faceted phospholipid vesicles tailored for the delivery of <italic>Santolina insularis</italic> essential oil to the skin</article-title><source>Colloids Surf. B Biointerfaces</source><year>2015</year><volume>132</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.05.025</pub-id><pub-id pub-id-type="pmid">26057243</pub-id></element-citation></ref><ref id="B91-biomolecules-09-00138"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>F.C.</given-names></name><name><surname>de Lima</surname><given-names>J.A.</given-names></name><name><surname>da Silva</surname><given-names>C.R.</given-names></name><name><surname>Benvegn&#x000fa;</surname><given-names>D.</given-names></name><name><surname>Ferreira</surname><given-names>J.</given-names></name><name><surname>Burger</surname><given-names>M.E.</given-names></name><name><surname>Beck</surname><given-names>R.C.R.</given-names></name><name><surname>Rolim</surname><given-names>C.M.B.</given-names></name><name><surname>Rocha</surname><given-names>M.I.U.M.</given-names></name><name><surname>da Veiga</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Hydrogels Containing Nanocapsules and Nanoemulsions of Tea Tree Oil Provide Antiedematogenic Effect and Improved Skin Wound Healing</article-title><source>J. Nanosci. Nanotechnol.</source><year>2015</year><volume>15</volume><fpage>800</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1166/jnn.2015.9176</pub-id><pub-id pub-id-type="pmid">26328444</pub-id></element-citation></ref><ref id="B92-biomolecules-09-00138"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugumar</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>V.</given-names></name><name><surname>Nirmala</surname><given-names>M.J.</given-names></name><name><surname>Mukherjee</surname><given-names>A.</given-names></name><name><surname>Chandrasekaran</surname><given-names>N.</given-names></name></person-group><article-title>Ultrasonic emulsification of eucalyptus oil nanoemulsion: Antibacterial activity against Staphylococcus aureus and wound healing activity in Wistar rats</article-title><source>Ultrason. Sonochem.</source><year>2014</year><volume>21</volume><fpage>1044</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1016/j.ultsonch.2013.10.021</pub-id><?supplied-pmid 24262758?><pub-id pub-id-type="pmid">24262758</pub-id></element-citation></ref><ref id="B93-biomolecules-09-00138"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonglairoum</surname><given-names>P.</given-names></name><name><surname>Chuchote</surname><given-names>T.</given-names></name><name><surname>Ngawhirunpat</surname><given-names>T.</given-names></name><name><surname>Rojanarata</surname><given-names>T.</given-names></name><name><surname>Opanasopit</surname><given-names>P.</given-names></name></person-group><article-title>Encapsulation of plai oil/2-hydroxypropyl-&#x003b2;-cyclodextrin inclusion complexes in polyvinylpyrrolidone (PVP) electrospun nanofibers for topical application</article-title><source>Pharm. Dev. Technol.</source><year>2014</year><volume>19</volume><fpage>430</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.3109/10837450.2013.788659</pub-id><?supplied-pmid 23651060?><pub-id pub-id-type="pmid">23651060</pub-id></element-citation></ref><ref id="B94-biomolecules-09-00138"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielli</surname><given-names>L.J.</given-names></name><name><surname>Dos Reis</surname><given-names>M.</given-names></name><name><surname>Bianchini</surname><given-names>M.</given-names></name><name><surname>Camargo</surname><given-names>G.S.</given-names></name><name><surname>Bordignon</surname><given-names>S.A.</given-names></name><name><surname>Guerreiro</surname><given-names>I.K.</given-names></name><name><surname>Fuentefria</surname><given-names>A.</given-names></name><name><surname>Apel</surname><given-names>M.A.</given-names></name></person-group><article-title>Antidermatophytic activity of volatile oil and nanoemulsion of <italic>Stenachaenium megapotamicum</italic> (Spreng.) Baker</article-title><source>Ind. Crop. Prod.</source><year>2013</year><volume>50</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2013.07.027</pub-id></element-citation></ref><ref id="B95-biomolecules-09-00138"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortan</surname><given-names>A.</given-names></name><name><surname>Ferdes</surname><given-names>M.</given-names></name><name><surname>Rodino</surname><given-names>S.</given-names></name><name><surname>Pirvu</surname><given-names>C.D.</given-names></name><name><surname>Draganescu</surname><given-names>D.</given-names></name></person-group><article-title>Liposomally encapsulated volatile oil of <italic>Anethum graveolens</italic></article-title><source>Farmacia</source><year>2013</year><volume>61</volume><fpage>361</fpage><lpage>370</lpage></element-citation></ref><ref id="B96-biomolecules-09-00138"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>F.C.</given-names></name><name><surname>Lima</surname><given-names>J.A.</given-names></name><name><surname>Ribeiro</surname><given-names>R.F.</given-names></name><name><surname>Alves</surname><given-names>S.H.</given-names></name><name><surname>Rolim</surname><given-names>C.M.B.</given-names></name><name><surname>Beck</surname><given-names>R.C.R.</given-names></name><name><surname>Silva</surname><given-names>C.B.</given-names></name><name><surname>De Lima</surname><given-names>J.A.</given-names></name><name><surname>Da Silva</surname><given-names>C.B.</given-names></name></person-group><article-title>Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of <italic>Trichophyton rubrum</italic></article-title><source>Mycopathologia</source><year>2013</year><volume>175</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1007/s11046-013-9622-7</pub-id><?supplied-pmid 23392821?><pub-id pub-id-type="pmid">23392821</pub-id></element-citation></ref><ref id="B97-biomolecules-09-00138"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>D.D.O.</given-names></name><name><surname>Colombo</surname><given-names>M.</given-names></name><name><surname>Kelmann</surname><given-names>R.G.</given-names></name><name><surname>De Souza</surname><given-names>T.P.</given-names></name><name><surname>Bassani</surname><given-names>V.L.</given-names></name><name><surname>Teixeira</surname><given-names>H.F.</given-names></name><name><surname>Veiga</surname><given-names>V.F.</given-names><suffix>Jr.</suffix></name><name><surname>Limberger</surname><given-names>R.P.</given-names></name><name><surname>Koester</surname><given-names>L.S.</given-names></name></person-group><article-title>Optimization of headspace solid-phase microextraction for analysis of &#x003b2;-caryophyllene in a nanoemulsion dosage form prepared with copaiba (<italic>Copaifera multijuga</italic> Hayne) oil</article-title><source>Anal. Chim.</source><year>2012</year><volume>721</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.aca.2012.01.055</pub-id><?supplied-pmid 22405303?><pub-id pub-id-type="pmid">22405303</pub-id></element-citation></ref><ref id="B98-biomolecules-09-00138"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.S.</given-names></name><name><surname>Alam</surname><given-names>M.S.</given-names></name><name><surname>Imam</surname><given-names>F.I.</given-names></name><name><surname>Siddiqui</surname><given-names>M.R.</given-names></name></person-group><article-title>Topical nanoemulsion of turmeric oil for psoriasis: Characterization, ex vivo and in vivo assessment</article-title><source>Int. J. Drug Deliv.</source><year>2012</year><volume>4</volume><pub-id pub-id-type="doi">10.5138/ijdd.v4i2.575</pub-id></element-citation></ref><ref id="B99-biomolecules-09-00138"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakulku</surname><given-names>U.</given-names></name><name><surname>Nuchuchua</surname><given-names>O.</given-names></name><name><surname>Uawongyart</surname><given-names>N.</given-names></name><name><surname>Puttipipatkhachorn</surname><given-names>S.</given-names></name><name><surname>Soottitantawat</surname><given-names>A.</given-names></name><name><surname>Ruktanonchai</surname><given-names>U.</given-names></name></person-group><article-title>Characterization and mosquito repellent activity of citronella oil nanoemulsion</article-title><source>Int. J. Pharm.</source><year>2009</year><volume>372</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2008.12.029</pub-id><pub-id pub-id-type="pmid">19162149</pub-id></element-citation></ref><ref id="B100-biomolecules-09-00138"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>F.</given-names></name><name><surname>Sinico</surname><given-names>C.</given-names></name><name><surname>De Logu</surname><given-names>A.</given-names></name><name><surname>Zaru</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.H.</given-names></name><name><surname>Fadda</surname><given-names>A.M.</given-names></name></person-group><article-title>SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study</article-title><source>Int. J. Nanomed.</source><year>2007</year><volume>2</volume><fpage>419</fpage><lpage>425</lpage></element-citation></ref><ref id="B101-biomolecules-09-00138"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suslina</surname><given-names>S.N.</given-names></name><name><surname>Alekseev</surname><given-names>K.V.</given-names></name><name><surname>Starodubova</surname><given-names>M.V.</given-names></name><name><surname>Bagirova</surname><given-names>V.L.</given-names></name></person-group><article-title>Drug synthesis methods and manufacturing technology: Development and comparative evaluation of a new liposomal dermatological preparation based on Viton oil</article-title><source>Pharm. Chem. J.</source><year>2004</year><volume>38</volume><fpage>492</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1007/s11094-005-0023-1</pub-id></element-citation></ref><ref id="B102-biomolecules-09-00138"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heather</surname><given-names>A.E.B.</given-names></name></person-group><article-title>Transdermal Drug Delivery: Penetration Enhancement Techniques</article-title><source>Curr. Drug Deliv.</source><year>2005</year><volume>2</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">16305405</pub-id></element-citation></ref><ref id="B103-biomolecules-09-00138"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnitzler</surname><given-names>P.</given-names></name><name><surname>Suschke</surname><given-names>U.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Saller</surname><given-names>R.</given-names></name></person-group><article-title>Essential Oils of Aromatic Plants with Antibacterial, Antifungal, Antiviral, and Cytotoxic Properties&#x02014;An Overview</article-title><source>Complement. Med. Res.</source><year>2009</year><volume>16</volume><fpage>79</fpage><lpage>90</lpage></element-citation></ref><ref id="B104-biomolecules-09-00138"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Matos</surname><given-names>S.P.</given-names></name><name><surname>Lucca</surname><given-names>L.G.</given-names></name><name><surname>Koester</surname><given-names>L.S.</given-names></name></person-group><article-title>Essential oils in nanostructured systems: Challenges in preparation and analytical methods</article-title><source>Talanta</source><year>2019</year><volume>195</volume><fpage>204</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.talanta.2018.11.029</pub-id><?supplied-pmid 30625533?><pub-id pub-id-type="pmid">30625533</pub-id></element-citation></ref><ref id="B105-biomolecules-09-00138"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Du</surname><given-names>S.</given-names></name></person-group><article-title>Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: Preparation optimization, in vitro dermal permeation, and in vivo bioevaluation</article-title><source>Int. J. Nanomed.</source><year>2016</year><volume>11</volume><fpage>2995</fpage><lpage>3007</lpage><pub-id pub-id-type="doi">10.2147/IJN.S105035</pub-id><?supplied-pmid 27486319?><pub-id pub-id-type="pmid">27486319</pub-id></element-citation></ref><ref id="B106-biomolecules-09-00138"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohani</surname><given-names>A.</given-names></name><name><surname>Verma</surname><given-names>A.</given-names></name></person-group><article-title>Vesicles: Potential nano carriers for the delivery of skin cosmetics</article-title><source>J. Cosmet. Ther.</source><year>2017</year><volume>19</volume><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1080/14764172.2017.1358451</pub-id><?supplied-pmid 28753057?><pub-id pub-id-type="pmid">28753057</pub-id></element-citation></ref><ref id="B107-biomolecules-09-00138"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conte</surname><given-names>R.</given-names></name><name><surname>Marturano</surname><given-names>V.</given-names></name><name><surname>Peluso</surname><given-names>G.</given-names></name><name><surname>Calarco</surname><given-names>A.</given-names></name><name><surname>Cerruti</surname><given-names>P.</given-names></name><name><surname>Andrade</surname><given-names>P.</given-names></name><name><surname>Valent&#x000e3;o</surname><given-names>P.</given-names></name></person-group><article-title>Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>709</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18040709</pub-id></element-citation></ref><ref id="B108-biomolecules-09-00138"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cal</surname><given-names>K.</given-names></name><name><surname>Centkowska</surname><given-names>K.</given-names></name></person-group><article-title>Use of cyclodextrins in topical formulations: Practical aspects</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2008</year><volume>68</volume><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2007.08.002</pub-id><pub-id pub-id-type="pmid">17826046</pub-id></element-citation></ref><ref id="B109-biomolecules-09-00138"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadhwa</surname><given-names>G.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Chhabra</surname><given-names>L.</given-names></name><name><surname>Mahant</surname><given-names>S.</given-names></name><name><surname>Rao</surname><given-names>R.</given-names></name></person-group><article-title>Essential oil&#x02013;cyclodextrin complexes: An updated review</article-title><source>J. Incl. Phenom. Macrocycl. Chem.</source><year>2017</year><volume>89</volume><fpage>39</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s10847-017-0744-2</pub-id></element-citation></ref><ref id="B110-biomolecules-09-00138"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>H.M.C.</given-names></name></person-group><article-title>A review on cyclodextrin encapsulation of essential oils and volatiles</article-title><source>Flavour Fragr. J.</source><year>2010</year><volume>25</volume><fpage>313</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1002/ffj.2019</pub-id></element-citation></ref><ref id="B111-biomolecules-09-00138"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mura</surname><given-names>S.</given-names></name><name><surname>Manconi</surname><given-names>M.</given-names></name><name><surname>Fadda</surname><given-names>A.M.</given-names></name><name><surname>Sala</surname><given-names>M.C.</given-names></name><name><surname>Perricci</surname><given-names>J.</given-names></name><name><surname>Pini</surname><given-names>E.</given-names></name><name><surname>Sinico</surname><given-names>C.</given-names></name></person-group><article-title>Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: In vitro evaluation of drug permeation by infrared spectroscopy</article-title><source>Pharm. Dev. Technol.</source><year>2013</year><volume>18</volume><fpage>1339</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.3109/10837450.2012.685661</pub-id><pub-id pub-id-type="pmid">22563642</pub-id></element-citation></ref><ref id="B112-biomolecules-09-00138"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>L.T.</given-names></name><name><surname>Gerber</surname><given-names>M.</given-names></name><name><surname>Du Plessis</surname><given-names>J.</given-names></name><name><surname>Hamman</surname><given-names>J.H.</given-names></name></person-group><article-title>Transdermal Drug Delivery Enhancement by Compounds of Natural Origin</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>10507</fpage><lpage>10540</lpage><pub-id pub-id-type="doi">10.3390/molecules161210507</pub-id></element-citation></ref><ref id="B113-biomolecules-09-00138"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinico</surname><given-names>C.</given-names></name><name><surname>Fadda</surname><given-names>A.M.</given-names></name></person-group><article-title>Vesicular carriers for dermal drug delivery</article-title><source>Opin. Drug Deliv.</source><year>2009</year><volume>6</volume><fpage>813</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1517/17425240903071029</pub-id><?supplied-pmid 19569979?><pub-id pub-id-type="pmid">19569979</pub-id></element-citation></ref><ref id="B114-biomolecules-09-00138"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalko</surname><given-names>J.</given-names></name><name><surname>Api</surname><given-names>A.</given-names></name></person-group><article-title>Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay</article-title><source>Chem. Toxicol.</source><year>2006</year><volume>44</volume><fpage>739</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2005.10.006</pub-id><?supplied-pmid 16324777?><pub-id pub-id-type="pmid">16324777</pub-id></element-citation></ref><ref id="B115-biomolecules-09-00138"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aqil</surname><given-names>M.</given-names></name><name><surname>Ahad</surname><given-names>A.</given-names></name><name><surname>Sultana</surname><given-names>Y.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Aqil</surname><given-names>M.</given-names></name></person-group><article-title>Status of terpenes as skin penetration enhancers</article-title><source>Drug Discov.</source><year>2007</year><volume>12</volume><fpage>1061</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2007.09.001</pub-id><?supplied-pmid 18061886?><pub-id pub-id-type="pmid">18061886</pub-id></element-citation></ref><ref id="B116-biomolecules-09-00138"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koul</surname><given-names>O.</given-names></name></person-group><article-title>Essential Oils as Green Pesticides: Potential and Constraints</article-title><source>Biopestic. Int.</source><year>2008</year><volume>4</volume><fpage>63</fpage><lpage>84</lpage></element-citation></ref><ref id="B117-biomolecules-09-00138"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanzi</surname><given-names>C.D.</given-names></name><name><surname>Vian</surname><given-names>M.A.</given-names></name><name><surname>Gini&#x000e8;s</surname><given-names>C.</given-names></name><name><surname>Elmaataoui</surname><given-names>M.</given-names></name><name><surname>Chemat</surname><given-names>F.</given-names></name></person-group><article-title>Terpenes as Green Solvents for Extraction of Oil from Microalgae</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>8196</fpage><lpage>8205</lpage><pub-id pub-id-type="doi">10.3390/molecules17078196</pub-id><pub-id pub-id-type="pmid">22777188</pub-id></element-citation></ref><ref id="B118-biomolecules-09-00138"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marturano</surname><given-names>V.</given-names></name><name><surname>Bizzarro</surname><given-names>V.</given-names></name><name><surname>De Luise</surname><given-names>A.</given-names></name><name><surname>Calarco</surname><given-names>A.</given-names></name><name><surname>Ambrogi</surname><given-names>V.</given-names></name><name><surname>Giamberini</surname><given-names>M.</given-names></name><name><surname>Tylkowski</surname><given-names>B.</given-names></name><name><surname>Cerruti</surname><given-names>P.</given-names></name></person-group><article-title>Essential oils as solvents and core materials for the preparation of photo-responsive polymer nanocapsules</article-title><source>Nano Res.</source><year>2018</year><volume>11</volume><fpage>2783</fpage><lpage>2795</lpage><pub-id pub-id-type="doi">10.1007/s12274-017-1908-5</pub-id></element-citation></ref><ref id="B119-biomolecules-09-00138"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashwani</surname><given-names>Z.-U.-R.</given-names></name><name><surname>Khan</surname><given-names>M.A.</given-names></name><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Nadhman</surname><given-names>A.</given-names></name></person-group><article-title>Applications of plant terpenoids in the synthesis of colloidal silver nanoparticles</article-title><source>Adv. Sci.</source><year>2016</year><volume>234</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.cis.2016.04.008</pub-id></element-citation></ref><ref id="B120-biomolecules-09-00138"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rino-Issartier</surname><given-names>S.</given-names></name><name><surname>Gini&#x000e8;s</surname><given-names>C.</given-names></name><name><surname>Cravotto</surname><given-names>G.</given-names></name><name><surname>Chemat</surname><given-names>F.</given-names></name></person-group><article-title>A comparison of essential oils obtained from lavandin via different extraction processes: Ultrasound, microwave, turbohydrodistillation, steam and hydrodistillation</article-title><source>J. Chromatogr. A</source><year>2013</year><volume>1305</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2013.07.024</pub-id><pub-id pub-id-type="pmid">23890545</pub-id></element-citation></ref><ref id="B121-biomolecules-09-00138"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastas</surname><given-names>P.T.</given-names></name><name><surname>Kirchhoff</surname><given-names>M.M.</given-names></name></person-group><article-title>Origins, Current Status, and Future Challenges of Green Chemistry</article-title><source>Acc. Chem. Res.</source><year>2002</year><volume>35</volume><fpage>686</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1021/ar010065m</pub-id><pub-id pub-id-type="pmid">12234198</pub-id></element-citation></ref><ref id="B122-biomolecules-09-00138"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>J.L.</given-names></name></person-group><article-title>Green Chemistry, a Pharmaceutical Perspective</article-title><source>Org. Process. Res. Dev.</source><year>2006</year><volume>10</volume><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1021/op050227k</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="biomolecules-09-00138-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart representing the steps of literature survey and selection of research papers.</p></caption><graphic xlink:href="biomolecules-09-00138-g001"/></fig><fig id="biomolecules-09-00138-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Annual distribution of publications.</p></caption><graphic xlink:href="biomolecules-09-00138-g002"/></fig><fig id="biomolecules-09-00138-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Topical administration routes of nanoencapsulated essential oils (EO) containing terpenes and isolated terpenes.</p></caption><graphic xlink:href="biomolecules-09-00138-g003"/></fig><fig id="biomolecules-09-00138-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Application of EO/terpenes as excipients or bioactive ingredients in formulations.</p></caption><graphic xlink:href="biomolecules-09-00138-g004"/></fig><fig id="biomolecules-09-00138-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Nanostructured systems used in the encapsulation of essential oils containing terpenes and isolated terpenes as bioactive compounds for topical formulations. LS, liposomes, VS, vesicular systems, SLN, solid lipid nanoparticles, NLC, nanostructured lipid carriers, NE, nanoemulsions, NC, nanocapsules.</p></caption><graphic xlink:href="biomolecules-09-00138-g005"/></fig><fig id="biomolecules-09-00138-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Nanostructured systems used in formulations containing essential oils and/or isolated terpenes excipients for topical administration. IV: invasomes, PEV: permeation-enhancing vehicles.</p></caption><graphic xlink:href="biomolecules-09-00138-g006"/></fig><fig id="biomolecules-09-00138-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Monoterpenes used as permeation enhancers in nanostructured systems.</p></caption><graphic xlink:href="biomolecules-09-00138-g007"/></fig><table-wrap id="biomolecules-09-00138-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00138-t001_Table 1</object-id><label>Table 1</label><caption><p>Publications found in the literature concerning the encapsulation of isolated terpenes in nanostructured systems intended for topical administration.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Terpene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">System</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Administration Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Terpene Role in the Nanosystem</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B25-biomolecules-09-00138" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene, cineole, fenchone, and citral</td><td align="center" valign="middle" rowspan="1" colspan="1">Invasomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-acne</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B26-biomolecules-09-00138" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Ursolic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiarthritic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B27-biomolecules-09-00138" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanovesicles</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B28-biomolecules-09-00138" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Paeoniflorin</td><td align="center" valign="middle" rowspan="1" colspan="1">Ethosomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiarthritic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-biomolecules-09-00138" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Rebaudioside A</td><td align="center" valign="middle" rowspan="1" colspan="1">Ultra-small micelles</td><td align="center" valign="middle" rowspan="1" colspan="1">Ocular</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B30-biomolecules-09-00138" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Farnesol</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral</td><td align="center" valign="middle" rowspan="1" colspan="1">Antibiofilm</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-biomolecules-09-00138" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Eucaliptol</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transfollicular</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-biomolecules-09-00138" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Menthol</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Osteoporosis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B33-biomolecules-09-00138" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Tripterine</td><td align="center" valign="middle" rowspan="1" colspan="1">Phytosomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B34-biomolecules-09-00138" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Ursolic acid and anethole</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive and excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B10-biomolecules-09-00138" ref-type="bibr">10</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Thymol</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B35-biomolecules-09-00138" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Docetaxel</td><td align="center" valign="middle" rowspan="1" colspan="1">Polymeric nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B36-biomolecules-09-00138" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Forskolin</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanostructures lipid carriers</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Photoprotector</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-biomolecules-09-00138" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Citral and limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Transferosomes and liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiarthritic</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-biomolecules-09-00138" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Paeoniflorin</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycerosomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive and Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B39-biomolecules-09-00138" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Transinvasomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B40-biomolecules-09-00138" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">PEGylated liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Alzheimer&#x02019;s treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-biomolecules-09-00138" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Triptolide</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Percutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory and analgesic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B42-biomolecules-09-00138" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-citronellene</td><td align="center" valign="middle" rowspan="1" colspan="1">Invasomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B43-biomolecules-09-00138" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-bisabolol</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanocapsules</td><td align="center" valign="middle" rowspan="1" colspan="1">Ocular</td><td align="center" valign="middle" rowspan="1" colspan="1">Antinociceptive</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B11-biomolecules-09-00138" ref-type="bibr">11</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperforin</td><td align="center" valign="middle" rowspan="1" colspan="1">Hydroxypropyl-&#x003b2;-cyclodextrin</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B44-biomolecules-09-00138" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Cineole and limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Penetration enhancer vehicle</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-biomolecules-09-00138" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-citronellene</td><td align="center" valign="middle" rowspan="1" colspan="1">Invasomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B46-biomolecules-09-00138" ref-type="bibr">46</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Squalene</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Immunization</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B14-biomolecules-09-00138" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Paclitaxel</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid Lipid Nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B47-biomolecules-09-00138" ref-type="bibr">47</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Madecassoside</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-biomolecules-09-00138" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Asiaticoside</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanofibers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B49-biomolecules-09-00138" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Triterpenoids of <italic>Ganoderma l.</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Nanogel</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Frostbite treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-biomolecules-09-00138" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Safranal</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">Cerebral ischemia treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B51-biomolecules-09-00138" ref-type="bibr">51</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Ursolic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Niosomal gel</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiarthritic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B52-biomolecules-09-00138" ref-type="bibr">52</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Farnesol</td><td align="center" valign="middle" rowspan="1" colspan="1">Polymeric nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral</td><td align="center" valign="middle" rowspan="1" colspan="1">Antibiofilm</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B53-biomolecules-09-00138" ref-type="bibr">53</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Ursolic acid and oleanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B13-biomolecules-09-00138" ref-type="bibr">13</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Docetaxel</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanofibers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B54-biomolecules-09-00138" ref-type="bibr">54</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B55-biomolecules-09-00138" ref-type="bibr">55</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Limoneno</td><td align="center" valign="middle" rowspan="1" colspan="1">PEGilated liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B56-biomolecules-09-00138" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene and 1,8-cineole</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion and solid lipid nanoparticles and nanostructures lipid carriers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous lesions treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B12-biomolecules-09-00138" ref-type="bibr">12</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Paclitaxel</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles and Nanostructures lipid carriers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperkeratosis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B57-biomolecules-09-00138" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Betulin</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B58-biomolecules-09-00138" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Analgesic</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B59-biomolecules-09-00138" ref-type="bibr">59</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Astragaloside IV</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B60-biomolecules-09-00138" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B61-biomolecules-09-00138" ref-type="bibr">61</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Lupane</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Leishmanicidal</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B62-biomolecules-09-00138" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Hurpezine A</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles, Nanostructures lipid carriers and Microemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Alzheimer&#x02019;s treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-biomolecules-09-00138" ref-type="bibr">63</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1">Tripterine</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanostructures lipid carriers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antineoplastic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B64-biomolecules-09-00138" ref-type="bibr">64</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1">Asiaticoside</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Stimulation of collagen synthesis</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B65-biomolecules-09-00138" ref-type="bibr">65</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" rowspan="1" colspan="1">Triptolide</td><td align="center" valign="middle" rowspan="1" colspan="1">Ethosomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B66-biomolecules-09-00138" ref-type="bibr">66</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" rowspan="1" colspan="1">Squalene</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanostructures lipid carriers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Psoriasis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B67-biomolecules-09-00138" ref-type="bibr">67</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" rowspan="1" colspan="1">Cineole</td><td align="center" valign="middle" rowspan="1" colspan="1">Penetration enhancer vehicle</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Alopecia treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B68-biomolecules-09-00138" ref-type="bibr">68</xref>,<xref rid="B69-biomolecules-09-00138" ref-type="bibr">69</xref>,<xref rid="B70-biomolecules-09-00138" ref-type="bibr">70</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2009, 2008</td><td align="center" valign="middle" rowspan="1" colspan="1">Limonene, citral and cineole</td><td align="center" valign="middle" rowspan="1" colspan="1">Invasomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Photosensitization</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B71-biomolecules-09-00138" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2005</td><td align="center" valign="middle" rowspan="1" colspan="1">Triptolide</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B72-biomolecules-09-00138" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2003</td><td align="center" valign="middle" rowspan="1" colspan="1">Sericoside</td><td align="center" valign="middle" rowspan="1" colspan="1">derivates of &#x003b2;- and &#x003b3;-cyclodextrins</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B73-biomolecules-09-00138" ref-type="bibr">73</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2003</td><td align="center" valign="middle" rowspan="1" colspan="1">Triptolide</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid lipid nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-biomolecules-09-00138" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1989</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forskolin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;- and &#x003b3;-cyclodextrins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ocular</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of intraocular hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioactive</td></tr></tbody></table><table-wrap-foot><fn><p>NA: not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap id="biomolecules-09-00138-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00138-t002_Table 2</object-id><label>Table 2</label><caption><p>Publications found in the literature concerning the encapsulation of essential oils, fixed oils, and plant extract containing terpenes in nanostructured systems intended for topical administration.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Essential Oil/Fixed Oil/Plant Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">System</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Administration Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Essential Oil/Fixed Oil/Plant Extract Role in the System</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B74-biomolecules-09-00138" ref-type="bibr">74</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Lemon EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperpigmentation treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B75-biomolecules-09-00138" ref-type="bibr">75</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Clove EO and sweet fennel EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Autoimmune dermatoses</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B76-biomolecules-09-00138" ref-type="bibr">76</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Clove EO and sweet fennel EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Autoimmune dermatoses</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-biomolecules-09-00138" ref-type="bibr">77</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Mentha EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanogel</td><td align="center" valign="middle" rowspan="1" colspan="1">Vaginal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B78-biomolecules-09-00138" ref-type="bibr">78</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Nigella Sativa</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsions</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B79-biomolecules-09-00138" ref-type="bibr">79</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Clove EO and Sweet Fennel EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Autoimmune dermatoses</td><td align="center" valign="middle" rowspan="1" colspan="1">Excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B80-biomolecules-09-00138" ref-type="bibr">80</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Cymbopogon Flexuous</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanocapsules</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B81-biomolecules-09-00138" ref-type="bibr">81</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Rosemary EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Lipid Nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Skin hydration</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B82-biomolecules-09-00138" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Eucaliptus globulosus</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanosized-microemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Repellent</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B83-biomolecules-09-00138" ref-type="bibr">83</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Syzygium aromaticum</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing and antidermatophytic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B84-biomolecules-09-00138" ref-type="bibr">84</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Tea Tree Oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B85-biomolecules-09-00138" ref-type="bibr">85</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Centella asiatica</italic> extract</td><td align="center" valign="middle" rowspan="1" colspan="1">Hydroxypropyl-&#x003b2;-cyclodextrin</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B86-biomolecules-09-00138" ref-type="bibr">86</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Lippia sidoides</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanogel</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral</td><td align="center" valign="middle" rowspan="1" colspan="1">Periodontitis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B87-biomolecules-09-00138" ref-type="bibr">87</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Foeniculum vulgare</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Transdermal</td><td align="center" valign="middle" rowspan="1" colspan="1">Antidiabetic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B88-biomolecules-09-00138" ref-type="bibr">88</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Lemongrass oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanosponges</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-biomolecules-09-00138" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Copaifera multijuga EO</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Percutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-biomolecules-09-00138" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Santolina insularis</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Penetration enhancing vehicle</td><td align="center" valign="middle" rowspan="1" colspan="1">Percutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive and excipient</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B91-biomolecules-09-00138" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Melaleuca alternifolia</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion and Nanocapsules</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Wound healing and antidermatotophytic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B92-biomolecules-09-00138" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Eucalyptus oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antibacterial and Wound healing</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B93-biomolecules-09-00138" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Plai oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Hydroxypropyl-&#x003b2;-cyclodextrin and Nanofibers</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-biomolecules-09-00138" ref-type="bibr">94</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Stenachaenium megapotamicum</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antidermatophytic</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B95-biomolecules-09-00138" ref-type="bibr">95</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Anethum graveolens</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B96-biomolecules-09-00138" ref-type="bibr">96</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>M. alternifolia</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion and nanocapsules</td><td align="center" valign="middle" rowspan="1" colspan="1">Ungueal</td><td align="center" valign="middle" rowspan="1" colspan="1">Onychomycosis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B97-biomolecules-09-00138" ref-type="bibr">97</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Percutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B98-biomolecules-09-00138" ref-type="bibr">98</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1">Turmeric oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Psoriasis treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B99-biomolecules-09-00138" ref-type="bibr">99</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" rowspan="1" colspan="1">Citronella oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Nanoemulsion</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Repellent</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B100-biomolecules-09-00138" ref-type="bibr">100</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2007</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Artemisia arborescens</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">Solid Lipid Nanoparticles</td><td align="center" valign="middle" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiviral</td><td align="center" valign="middle" rowspan="1" colspan="1">Bioactive</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-biomolecules-09-00138" ref-type="bibr">101</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viton oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liposomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cutaneous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioactive</td></tr></tbody></table></table-wrap></floats-group></article>